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This thesis comprises two parts. The first part addresses structural and biochemical studies of 
proteins involved in polyamine transport in Pseudomonas aeruginosa PAO1. The second part 
briefly describes an in vitro assembly of decapping activator Lsm1-7-Pat1-465c eight-protein 
complex involved in mRNA decay and a preliminary structural study of the carboxyl 
terminal domain of Pat1 which plays an important role in mRNA decay and translational 
repression.  
Part I Structural and biochemical studies of proteins involved in polyamine transport 
from Pseudomonas aeruginosa PAO1 
Summary 
Polyamines (putrescine, spermidine and spermine) are naturally small polycationic molecules 
and play important roles in DNA condensation, DNA-protein interaction, embryonic 
development and cancer development. In Pseudomonas aeruginosa, spuDEFGH proteins are 
supposed to be a spermidine transport ATP binding cassette (ABC) system, in which spuD 
and spuE are the periplasmic spermidine binding proteins. Moreover, this system plays a role 
in the regulation of type III secretion system (T3SS), one of the important virulence 
determinants in Gram-negative bacteria. In this study, spuD is found to be a putrescine 
binding protein and has no role in the T3SS gene expression. In contrast, spuE is a 
spermidine binding protein and shows a distinct effect upon the T3SS gene expression. 
Furthermore, we solved four structures including spuD in apo open form, spuD in putrescine-
bound closed form, spuE in apo open form and spuE in spermidine-bound closed form. This 
is the first report in which both putresine and spermidine binding proteins in both apo and 
ligand-bound forms are presented. Comparison of these four structures reveals novel insight 
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into the basis of polyamine binding specificity, as well as direct insight into the 
conformational changes associated with ligand binding. 
Chapter 1 introduction 
Polyamines (putrescine, spermidine and spermine) are naturally occurring small linear 
polycationic molecules. They are important regulators of a wide spectrum of processes at 
both the molecular and cellular levels (Thomas and Thomas 2001). As regulators, they 
themselves are also regulated tightly so as to adapt to dynamic cellular changes (Thomas and 
Thomas 2001). Metabolic regulations of polyamines consist of synthesis, degradation and 
transport (uptake and excretion) (Igarashi and Kashiwagi 1999). Polyamines are found to be 
involved in cancers such as prostatic and colorectal cancer and infectious diseases such as 
African sleeping sickness (Wallace 2003). Given their roles in disease, designing polyamine 
inhibitors (analogues or derivatives) may have potential therapeutic effects in the treatment 
of such diseases (Wallace 2003). 
  Recent study has implicated polyamines as a specific regulator of the type III secretion 
system (T3SS), one of the essential virulence determinants in a Gram negative bacterium, 
Pseudomonas aeruginosa (Zhou et al. 2007; Hauser 2009). Pseudomonas aeruginosa is a 
serious human pathogen. It is resistant to most of the current antibiotics treatments and hence 
poses a mortal threat to immuno-compromised patients. In this chapter, an overview of the 
polyamine metabolic pathways in bacteria will be given, followed by a review of the current 
knowledge of the physiological and pathological roles of polyamine and potential 
applications of polyamine inhibitors in disease treatment. Finally, the implications of 
polyamines in the virulence of Pseudomonas aeruginosa will be reviewed.  
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Section 1.1 Polyamine metabolism 
Polyamines are small, natural molecules consisting of an aliphatic hydrocarbon backbone of 
flexible length and interspersed positively charged amino groups at physiological pH. 
Polyamines identified include putrescine (1,4-diaminobutane), spermidine ([N-(3- 
aminopropyl) butane-1,4-diamine]) and spermine ([N,N′- bis(3-aminopropyl)butane-1,4-
diamine]) (Figure I-1). A polyamine is defined by the number of amine groups it contains. 
As shown in Figure I-1, putrescine is divalent, spermidine is trivalent and spermine is 
tetravalent. Putrescine and spermidine are found widely in both prokaryotes and eukaryotes, 
while spermine is found exclusively in eukaryotes (Thomas and Thomas 2001). Regulation 
of polyamine metabolism consists of synthesis, degradation and transport (uptake and 
excretion) processes (Igarashi and Kashiwagi 1999). Polyamine synthesis and degradation 
are well conserved in both prokaryotes and eukaryotes (Childs et al. 2003). However, while 
much is known about polyamine transport in E. coli, most genes involved in eukaryotic 
polyamine transport have not yet been identified. Hence in the following sections, discussion 










   
Figure I-1. Structures of polyamines. The position of nitrogen and carbon atoms in 
putrescine and spermidine is labeled for the convenience of structural analysis in the Results 
and Discussion sections below. 
1.1.1 Synthesis 
In bacteria, putrescine and spermidine are the two most widely utilized polyamines within the 
cells. In contrast, cadaverine is the least abundant among all natural polyamines. Cadaverine 
is only synthesized under rare conditions such as in anaerobicity and low pH, or in the 
absence of putrescine synthesis. It can be synthesized via catalysis by lysine decarboxylase 
(CadA) from the precursor lysine when this residue is in abundance (Watson et al. 1992). 
The synthesis pathway of spermine has not been identified to date, however, it seems that 
exogenous spermine is sufficient to satisfy the cellular requirements and therefore bacteria do 
not need a self synthesis system. Another interpretation might be that spermine plays a trivial 
role in the metabolism of bacteria and is hence not needed in copious amounts. 
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    In E. coli and many Pseudomonas species, two major putrescine synthesis pathways 
(Figure I-2) have been described (Childs et al. 2003). In the first pathway, ornithine is the 
precursor and catalyzed to putrescine by ornithine decarboxylase (ODC), which is encoded 
by the speC gene. In the second pathway, arginine is the precursor and catalyzed via the 
intermediate agmatine by SpeA (arginine decarboxylase) to the end product putrescine by 
SpeB (agmatinase). In Pseudomonas aeruginosa, a third pathway of putrescine synthesis has 
been identified in which agamatine is hydrolyzed to putrescine via N-carbamoylputrescine 
(Nakada and Itoh 2003).  
  Spermidine synthesis involves the initial conversion of methione to S-adenosyl methionine 
(SAM) by the enzyme methionine adenosyltransferase (SAM synthetase encoded by metK), 
followed by conversion to decarboxylated SAM by SAM decarboxylase (speD). Finally, 
putrescine and decarboxylated SAM are catalyzed as the substrates of spermidine synthase 
(speE) to spermidine (Tabor et al. 1986). 
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Figure I-2. Polyamine synthesis and degradation pathways. Putrescine is synthesized via 
two pathways. The first is the conversion of ornithine to putrescine by ornithine 
decarboxylase (ODC), and the other is the conversion of arginine to the intermediate product 
agmatine by arginine decarboxylase (ADC) and then to putrescine by agmatinase. S-
Adenosylmethione decarboxylase (SAMDC), spermidine (Spd) synthase and spermine (Spm) 
synthase catalyze putrescine to spermidine and spermine, respectively. Spermine is converted 
to spermidine and putrescine by spermine/spermidine N1-acetyltransterase (SSAT) and 




Polyamine degradation (Figure I-2) is considered as an interconversion cycle (Seiler 2004). 
Two major enzymes have been implicated in the degradation of spermine, spermidine and 
putrescine. Spermidine and spermine are first acetylated to N1-acetylspermidine (N1acSpd) 
and N1-acetylspermine (N1acSpm) by spermidine/spermine-N1-acetyltransferase (SSAT). 
Following acetylation, spermine and spermidine are catalyzed by polyamine oxidase (PAO) 
to produce spermidine and putrescine, respectively. This is coupled to the production of 
aldehyde and highly oxidative hydrogen peroxide (H2O2). As the generated spermidine and 
putrescine can be reused, this cycle is then called an interconversion cycle.   
1.1.3 Transport (Uptake and Secretion) 
In E. coli, several polyamine transport systems have been identified (Figure I-3). One is the 
spermidine preferential uptake system involving four proteins known as potABCD; the other 
is a putrescine-specific uptake system composed of a potFGHI four-protein complex 
(Kashiwagi et al. 1990; Furuchi et al. 1991). Both uptake systems belong to the ATP binding 
cassette (ABC) transporter family (Higgins 1992), which comprises one periplasmic binding 
protein (PBP) for substrate capture (potD or potF), two transmembrane proteins for channel 
formation (potBC or potHI), and one membrane-associated ATPase (potA or potG) for 
energy consumption coupled with polyamine uptake. Another polyamine transport system 
has been identified (potE), which shows pH dependent activity (Kashiwagi et al. 2000). In 
acidic medium it execretes putrescine and uptakes ornithine while in neutral medium it 
uptakes putrescine (Kashiwagi et al. 2000). This pH-dependent polyamine transport activity 
may imply that the transport systems in E. coli are highly sensitive and efficient in adjusting 
to the changes in external environment. The spermidine excretion system has been identified 
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for E. coli when grown in neutral medium (Higashi et al. 2008). In this system, members of 
the drug exporter family, MdtJI, are involved in the excretion activity.  
 
Figure I-3. Polyamine transport systems in E. coli.  Spermidine uptake system is 
composed of potABCD proteins of which the periplasmic binding protein potD binds and 
transfers spermdine through the membrane channel formed by potB and potC. This process is 
coupled to ATP hydrolysis by the ATPase potA. Similarly, putrescine is transported by the 
potFGHI system. Here, potF is the periplasmic putrescine-binding protein, while potH and 
potI form the transmembrane channel proteins and potG hydrolyzes ATP during putrescine 
transport. PotE shows pH-depenedent putrescine transport activity. Figure is adapted from 
the reference Igarashi and Kashiwagi 1999. 
 
  Periplasmic binding proteins (PBP) are found in bacteria and act as receptors of a wide  
spectrum of small molecule substrates for transport and chemotaxis (Tam and Saier 1993). 
PBPs show high binding affinity and specificity to their ligands and are generally thought to 
switch between open and closed forms upon ligand binding and ligand release. Free PBPs 
show weak binding to their corresponding transmembrane channel proteins; however, the 
binding affinity between periplasmic binding proteins and their respective transmembrane 
protein increases when PBPs are loaded with their targets. Meanwhile, the interaction of 
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PBPs with their transmembrane channel proteins induces a conformational change of the 
channel proteins in order to accept the ligands from the PBPs. This process is energetically-
driven by the ATPase of each ABC transporter.  
Structures of potD in complex with spermidine and potF in complex with putrescine have 
been reported (Sugiyama et al. 1996a; Sugiyama et al. 1996b; Vassylyev et al. 1998). 
Recently, the structure of TppotD, a putrescine binding receptor from Treponema pallidum, 
has been solved (Machius et al. 2007). In this structure, two 2-(N-morpholino) ethanesulfonic 
acid molecules (Mes) that were used as a crystallization agent were found within the 
receptor. One Mes molecule was observed to overlap with the putrescine binding site after 
superposing with the structures of potD and potF.     
Section 1.2 Roles of polyamine at the molecular level 
1.2.1 DNA regulation 
Positively charged polyamines (putrescine, spermidine and spermine) interact with the 
phosphate groups of DNA via non-specific salt bridges (Ouameur and Tajmir-Riahi 2004). 
These non-specific salt bridge interactions are in the form of nuclear aggregates of 
polyamines (NAPs) in vivo (D'Agostino et al. 2005). There are three types of NAPs with 
approximate molecular weights of 1000 Da, 4800 Da and 8000 Da, respectively. The 
simplest formulas for 1000Da, 4800 Da and 8000 Da are Put-Ph-Spd-Ph-Spm, Put-Ph-Spd-
(Ph-Spm)2 and Put-Ph-Spd-(Ph-Spm)2, respectively (Put for putrescine, Spd for spermidine, 
Spm for spermine, Ph for phosphate group). These three types of NAPs can be assembled in 
vitro, which is in agreement with their in vivo function (Di Luccia et al. 2009). NAPs may 
influence the behavior of DNA in several aspects: (1) protection of DNA from damaging 
agents such as ionizing radiation and reactive oxygens (Khan et al. 1992; Spotheim-Maurizot 
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et al. 1995); (2) protection of DNA from exonuclease III and endonuclease cleavage 
including that of DNAse I (Pingoud et al. 1984); (3) induction of DNA condensation and 
hence genome packaging from around 1 meter in length to several micrometers in the 
nucleus due to the shielding of more than 90% of DNA’s negative charges (Wilson and 
Bloomfield 1979); (4) prevention of DNA fragmentation, which is often an onset of 
apoptosis; (5) induction of DNA transition from the right handed B-form to the left handed 
Z-form, wherein the Z form DNA is important in the regulation of the transcriptional 
activities of certain genes (Rich and Zhang 2003); and (6) stabilization of DNA from heat 
denaturation (Tabor 1961). As a result of these properties, derivatives of polyamines have 
been commercially developed and used as carriers for the delivery of anti-sense 
oligonucleotides into target cells to knock out specific genes (Bielinska et al. 1996). 
1.2.2. RNA regulation 
RNA comprises three types: tRNA, rRNA and mRNA. mRNA carries genetic information; 
rRNA is a major component of the translational machinery ribosome; and tRNA contains 
anticodon for basepairing to the triplet codon from mRNA while at the same time provides 
amino acid for peptide elongation. Evidence shows that polyamines can regulate these three 
types of RNAs. For example, purified tRNAs have been found to be associated with 
spermidine and Mg2+ (Quigley et al. 1978). Both spermidine and Mg2+ are important in 
modulating the conformation of tRNAs and their biological functions. Spermidine has been 
found to facilitate the crystallization of tRNAs in ethanol and the presence of spermidine in 
tRNAs has been confirmed from earlier crystallographic studies (Kim et al. 1971). 
Polyamines are also associated with the ribosomes from bacteria and eukaryotes (Bachrach 
2005). This suggests that they have a role in regulating the assembly of ribosomes, possibly 
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via an interaction with rRNAs, and hence protect RNA strand in the ribosome from 
degradation, thereby enhance protein synthesis (Bachrach 2005). Besides association with 
tRNA and ribosomes, polyamines are also found to modulate the stability of several specific 
mRNAs in intestinal epithelial cells (Wang 2007). For example, polyamine depletion 
stabilizes p53, junD and TGF β by increasing their half lives significantly. On the other hand, 
polyamine supplementation restores their half lives to wild type levels. In addition to the 
influence of polyamines upon mRNA stability, polyamines are found to induce a 
translational frameshift of some mRNAs, one of which is antizyme (Matsufuji et al. 1995). 
The sequence of antizyme mRNA contains a translational frameshift site and this site is 
sensitively regulated by the concentration of cellular polyamines. When the cellular 
concentration of polyamines exceeds a certain threshold, translation of frameshifting 
antizyme is stimulated. Subsequently, antizyme binds to the rate-limiting polyamine 
synthesis enzyme ornithine decarboxylase (ODC), induces the degradation of ODC and 
hence decreases the rate of polyamine synthesis. 
1.2.3 Protein regulation 
Most of the proteins that are involved in DNA binding are transcription factors. Polyamines 
have regulatory effects on many transcription factor-DNA interactions (Childs et al. 2003). 
For instance, the interactions of estrogen receptor (ER) and its response element (ERE), NF-
κB and its response element NRE, Oct-1 and its DNA response element, and several viral 
transcription factors ICP4, USF and TEF3 to their DNA response elements, are all regulated 
by polyamines in a concentration-dependent manner. However, as polyamines can induce a 
conformational change in DNA (reviewed in section 1.2.1), hence it may be possible that 
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regulation of DNA-protein interactions by polyamines might be via the regulation of the 
DNA molecule itself.  
  On the other hand, polyamines can directly bind some proteins and modulate their 
functions. For example, spermidine and spermine are found to bind the extracellular sites of 
the N-methyl-D-aspartate (NMDA) receptor and to regulate the transport efficiency of 
NMDA, which is an important neurological transmitter (Childs et al. 2003). Besides the 
NMDA receptor, polyamines can regulate many other transmitter receptors through direct 
interaction with these receptors (Childs et al. 2003). 
1.2.4 Post-translational modification 
Protein phosphorylation is a major post translational modification, which is carried out by 
protein kinases. Polyamines have been found to regulate the phosphorylation of many of 
these kinases, which are essential in the regulation of signal transduction and metabolic 
pathways. For example, stimulation of tyrosine kinase activity in NIH3T3 cultured cell 
requires polyamine synthesis (Auvinen et al. 1992). Phosphorylation of the kinase ERK1 and 
ERK2 in leukemia L1210 cells and human breast epithelial cells is modulated by polyamines 
(Bachrach 2005). The regulation of kinases involved in signal transduction or metabolism 
may in turn modulate the expression of many downstream genes. 
  Besides non-covalent modification of many protein kinases, polyamines are also involved in 
covalent protein modifications. eIF-5A is a ubiquitous eukaryotic translation initiation factor 
that contains a unique amino acid, hypusine [N-epsilon-(4-aminobutyl) lysine]. Formation of 
hypusine is a two-step enzymatic reaction. First, deoxyhypusine synthase catalyzes the 
transfer of a 4-aminobutyl moiety from the spermidine to a specific lysine residue in the eIF-
5A precursor protein to form an intermediate amino acid, deoxyhypusine. Secondly, this 
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intermediate deoxyhypusine is hydroxylated by deoxyhypusine hydroxylase to form the 
mature eIF-5A. eIF-5A is involved in cell proliferation and cell viability (Childs et al. 2003). 
Hypusine modified eIF-5A is found to regulate the processing of certain RNAs (Pollard and 
Malim 1998). Rev is the first RNA identified to be processed in a eIF-5A dependent manner. 
Rev encodes a viral protein of HIV 1 and it shuttles between the nucleus and cytoplasm of 
the host cell to mediate the translocation of the viral mRNAs of nonspliced or partially 
spliced species across the nuclear envelope and hence regulate the gene expression of HIV. It 
has a eIF-5A binding domain and it has been shown that binding of eIF-5A is essential for its 
proper function (Ruhl et al. 1993). In addition to modulation of RNA processing, further 
evidence points to a role in modulation of mRNA decay by hypusine-modified eIF-5A (Zuk 
and Jacobson 1998). A single amino acid substitution in yeast eIF-5A shows a defect in 
mRNA decay with accumulated uncapped mRNAs, suggesting the decay defect occurs 
downstream of mRNA decapping.  
Section 1.3 Roles of polyamine at the cellular level 
As polyamines have been demonstrated to exert important roles in the regulation of all the 
basic molecules, DNA, RNA and protein, roles of polyamines at the molecular level can be 
reemphasized at the cellular levels. These roles span the fundamental cellular processes 
including proliferation, differentiation, apoptosis, and cell cycle progression. 
1.3.1 Regulation of proliferation and differentiation 
Numerous studies show that polyamines are implicated in cell growth (Thomas and Thomas 
2001). Overexpression of polyamines is often found in many malignant cells, while depletion 
of polyamines causes cell growth arrest and may induce cell death. Addition of exogenous 
polyamines can reverse this cell growth arrest. Many enzymes involved in polyamine 
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metabolism are essential in regulation of cell growth. For example, mutants of S-
Adenosylmethione decarboxylase (SAMDC), the key enzyme for spermidine and spermine 
synthesis, cause growth arrest in Saccharomyces cerevisiae, Escherichia coli, mice embryos 
and Leishmania donovani (Childs et al. 2003). Disruption of ODC, the key enzyme for 
polyamine synthesis, causes Chinese hamster ovary cell death and failure of mice embryonic 
development (Steglich and Scheffler 1982; Pendeville et al. 2001). 
  Besides the involvement of proliferative regulation, polyamines are also found to affect 
differentiation. Inhibition of polyamine synthesis by DFMO, a specific ODC inhibitor, 
prevents 3T3-L1 fibroblasts and L6 myoblasts from differentiation (Bethell and Pegg 1981; 
Erwin et al. 1983). By contrast, addition of exogenous putrescine or spermidine restores the 
differentiation of 3T3-L1 and L6 cell lines into adipocytes and muscle cells respectively. As 
differentiation and proliferation are closely related, it is often difficult to distinguish the two 
processes clearly. Therefore it is possible that involvement of polyamines in the regulation of 
proliferation also intertwines with the regulation of cell differentiation. 
1.3.2 Regulation of apoptosis 
Polyamines have controversial roles in apoptosis. Some studies show that polyamines can 
inhibit apoptosis. For example, spermine can prevent the apoptosis induced by ionomycin, a 
Ca2+-stimulating agent produced in CD28- T-cells (Brune et al. 1991) and dexamethasone-
induced apoptosis in thymocytes can be blocked by the addition of polyamines (Desiderio et 
al. 1995). In contrast, some studies show that polyamines can induce apoptosis. In a 
particular study, overexpression of ODC, the key polyamine synthesis enzyme, can 
accelerate apoptosis induced by withdrawal of IL-3 from murine myeloid cells and this 
process is ODC dose-dependent (Packham and Cleveland 1994). Hence, addition of DFMO, 
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the inhibitor of ODC, can block ODC-induced apoptosis. Oxidation of spermidine and 
spermine by amine oxidase can induce apoptosis. This apoptosis induction is due to the 
production of highly oxidative H2O2 and highly reactive aminoaldehydes, which are strong 
apoptosis inducers (Parchment and Pierce 1989; Ha et al. 1997).   
1.3.3 Regulation of cell cycle 
Polyamines have distinct distribution peaks during cell cycle progression (Heby et al. 1973). 
The cell cycle is composed of four phases: G1, gap 1 or growh phase 1; S, the DNA synthesis 
phase; G2, gap 2 or growth phase 2; and M, the mitotic phase. Cyclins and cyclin-dependent 
kinases (CDKs) are the major cell cycle modulators. Six different cyclins (A, B1, D1, D2, D3 
and E) have been identified and they function at different phases of cell cycle (Thomas and 
Thomas 2001). In addition, cyclin-CDK is regulated by a group of molecules termed CDK 
inhibitors. Evidence shows that polyamines are involved in cell cycle regulation based on the 
following observations: (1) degradation of cyclin B1 requires the presence of polyamines and 
inhibition of polyamine synthesis by DFMO leads to cell cycle retardation (Thomas and 
Thomas 1994); (2) decrease of polyamines is correlated with the decrease of cyclin D1 and 
cell cycle blockage in the G1 phase (Thomas, 1997); (3) p21, an CDK inhibitor, is 
upregulated upon treatment with polyamine analogues, and growth arrest of melanoma cells 
is induced (Kramer et al. 1999).  
Section 1.4 Polyamines in embryonic development 
Accumulating evidence shows that polyamines have important roles in the embryonic 
development of commonly used model species. The earliest documented species for the 
study of polyamine and embryonic development may be the sea urchin. Sea urchin egg 
cleavage at the first, second and third stages is inhibited by α-methylornithine, an ODC 
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inhibitor (Kusunoki and Yasumasu 1978). This inhibition of egg cleavage is reversible upon 
addition of ornithine or polyamines within certain ranges of concentrations. In the chick 
embryo system, addition of DFMO, the ODC inhibitor, delays the development of erythroid 
cells, heart beating tube and adipocyte-like cells (Heby and Emanuelsson 1981). This delay 
may be associated with the disruption of nucleolar formation which is normally protected by 
polyamines. Treatment of DFMO also causes pregnancy abortion in rat and rabbit (Reddy 
and Rukmini 1981; O'Toole et al. 1989). In Caenorhabditis elegans, defective ODC causes 
embryonic developmental retardation (MacRae et al. 1998). Addition of exogenous 
polyamines can reverse this retardation. 
Section 1.5 polyamines and cancer 
Polyamines are essential for cell growth. However, overproduction of polyamines may 
induce abnormal cell growth and lead to neoplastic transformation. Accumulation of 
polyamines is often found in many cancerous tissues and body fluids of cancer patients. 
Concentrations of polyamines in body fluids such as blood and urinary may be used as a 
diagnostic tool for cancer and a therapeutic evaluation tool for drug treatment. Increased 
ODC activity is observed in many common cancers, such as colorectal cancer, prostate 
cancer, non-melanoma skin cancer, and breast cancer (Leveque et al. 2000; Milovic and 
Turchanowa 2003; Schipper et al. 2003; Gilmour 2007). Most of these cancers show poor 
prognostic outcomes despite extensive chemotherapy.  
 As such, blocking polyamine synthesis via ODC inhibitors will predictably exert a 
therapeutic role during cancer treatment. A specific ODC inhibitor, DFMO, was earlier 
proposed as a promising agent for cancer treatment through blocking polyamine synthesis. 
However, clinical test data showed that the expected therapeutic effects in cancer were weak 
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or poor, possibly due to the compensatory effect from the polyamine uptake system. 
Consistent with this view, polyamine uptake activity increased several folds after DMFO 
treatment and hence overall polyamine contents of putrescine and spermidine in cancer cell 
showed no obvious decrease compared to the cancer cell without DMFO treatment (Alhonen-
Hongisto et al. 1980; Bogle et al. 1994). Therefore, combinational therapy of blocking both 
polyamine synthesis and its uptake system will have a more thorough effect of polyamine 
depletion and hence promising response during cancer treatment. Recently, Burns and 
coworkers (Burns et al. 2009) used this combinational strategy to achieve a very exciting 
result upon treatment of several different cancer cell lines in a mouse cancer model. In their 
study, a spermine conjugate, D-Lys (C16acyl)-Spm was found to block spermidine transport 
in the nanomolar range and meanwhile cannot be taken up inside the cells. This suggests that 
the conjugate is an efficient spermidine transport inhibitor. Single use of either the conjugate 
or DMFO showed no growth inhibitory effect among several tested cancer cell lines, 
including breast (MDA-MB-231), prostate (PC-3), melanoma (A375), and ovarian (SK-OV-
3). In contrast, combination of DMFO and the conjugate dramatically displayed several 
orders of magnitude of cell growth inhibitory effect. More excitingly, the cell growth 
inhibitory effect of combinational treatment in vitro was also observed in a transgenic skin 
cancer mouse model with squamous cell carcinomas (SCC). 88% of SCCs showed “complete 
or nearly complete remission”. This is the first study demonstrating a therapeutic effect of 
polyamine depletion during cancer treatment. 
   All together, it is clear that polyamines play an important role in cancer cell growth. To 
achieve polyamine depletion and therapeutic effects in cancers requires blockage of both 
polyamine synthesis and uptake pathways. 
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Section 1.6 Pseudomonas aeruginosa PAO1 
1.6.1 General property and clinical state 
Pseudomonas aeruginosa (P. aeruginosa) is a Gram-negative bacterium with a large genome 
(Visca et al. 2002). Although functions of many predicted open reading frames in P. 
aeruginosa PAO1 genome are not clear, most identified genes have roles in the catabolism, 
regulation and transport of small molecules (Visca et al. 2002). The large genome reflects its 
flexibility in adaptation to diverse environmental conditions. P. aeruginosa is found nearly 
everywhere, including water, soil, plants, and animals (Bonten et al. 1999). It is an important 
opportunistic pathogen to patients in immuno-compromised states, such as organ-transplant 
patients treated by immuno-suppressors, burn victims, cancer and neutropenia patients, HIV 
1 patients, cystic fibrosis patients, and patients in intensive care units (Sadikot et al. 2005). It 
can form different types of infections in patients with different conditions, such as acute and 
severe infection in patients with ventilator-associated pneumonia (VAP), nosocomial 
pneumonia and community-acquired pneumonia. It can also cause chronic infections in 
patients with cystic fibrosis.  
  Unfortunately, P. aeruginosa is notoriously known as a multi-drug resistant bug and has 
been found to develop resistance to nearly every antibiotic to which it is exposed, such as 
fluoroquinolone, imipenem, ceftazidime, tobramycin, ciprofloxacin, polymyxin and 
carbapenem (Talbot et al. 2006; Boucher et al. 2009). Therefore very limited drugs are 
available for selection to fight this super-resistant bug. On the other hand, limited new drugs 
are under development. Resistance of P. aeruginosa to carbapenem, one antibiotic agent in 
clinical phase 2, has been recently reported (Talbot et al. 2006). Currently, the target sites of 
nearly all available or under-development antibiotics largely fall into the following three 
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categories, cell wall synthesis inhibitor, protein synthesis inhibitor and topoisomerase 
inhibitor (Talbot et al. 2006).  
  The resistance mechanisms include production of β-lactamases such as penicillinases, 
cephalosporinases, and carbapenemases which digest antibiotics (Walsh et al. 2005), 
activation of efflux systems to pump out antibiotics (Poole 2004), mutation of cell wall to 
block the travelling of antibiotics before reaching their target sites (Gales et al. 2001), and 
change of target structure (Schweizer 2003). Hence targeting efflux pump system or other 
new sites may help to alleviate the increasing drug resistance in P. aeruginosa. 
1.6.2 Virulence determinants 
Infection severity is dictated by virulence determinants in P. aeruginosa and the host 
immunological response (Sadikot et al. 2005; Driscoll et al. 2007). Virulence determinants in 
P. aeruginosa include flagellum, pili, biofilm, efflux pump, type III secretion system (T3SS) 
and other secreted factors such as exotoxin A, proteases and phenazines (Figure I-4). P. 
aeruginosa owns a single flagellum that controls its movement and several pili that are 
involved in attachment to injured epithelial cells such as in the respiratory tract, urinary tract 
or surgery site. Mucoid polysaccharide alginate is responsible for obstruction of bacteria 
clearance by the infected host and facilitation of biofilm formation. Biofilm is composed of a 
biopolymer matrix that shields bacteria inside in the form of microcolonies and enhances 
bacteria attachment to a surface. Quorum sensing is a cell-to-cell communication pathway 
through small molecules termed autoinducers. Quorum sensing is a dynamic process for 
bacteria to respond efficiently to their constantly changing external conditions. T3SS is a key 
virulence determinant in P. aeruginosa and via the T3SS bacteria contact and inject several 
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effector proteins inside the host cell directly. It is thought that biofilm is responsible for 
chronic infections whereas T3SS plays a major role in acute infections. 
 
                           
Figure I-4. Virulence determinants in P. aeruginosa. Figure is modified from the reference 
Driscoll et al. 2007.  
1.6.3 Type III secretion system (T3SS)   
T3SS is a multi-protein complex in Gram-negative bacteria. This secretion system (Figure I-
5) is constituted of at least 42 genes which can be grouped into five categories: a needle 
structure with a basal body across the inner membrane, the peptidoglycan layer, and the outer 
membrane, which is associated with a cytoplasmic bulb and protrudes into the bacterial 
extracellular surroundings; a translocation apparatus that dwells on the tip of the needle and 
punches holes through the host cell plasma membrane into the cytoplasm; proteins that 
regulate the process of secretion; chaperones that bind and enhance the delivery of their 
cognate partners through the needle syringe; effector proteins that are injected into the host 
cell through the needle and translocation apparatus (Enninga and Rosenshine 2009; Hauser 
2009).     
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  Of the 42 genes, a gene cluster of 36 genes, located within a chromosomal region of around 
26 kb and encoded by five operons, has been identified. These 36 genes function in the 
biogenesis and regulation of this T3SS complex. At least 6 other genes are scattered among 
the chromosomal region which encode the four effector proteins, exoS, exoT, exoY and 
exoU and two chaperones, spcS and spcU. 
  T3SS is regulated by environmental signals. Expression of T3SS can be induced by several 
types of environmental signals, such as calcium in low concentration, contact with eukaryotic 
host cells and high osmolarity (Yahr and Wolfgang 2006). ExsA, the master regulator of 
T3SS and encoded by the exsCEBA operon, coordinates T3SS gene expression induced by 
environmental signals, via binding to the promoter regions of known T3SS genes and 
activating their expression. When T3SS is under non-inducible conditions, exsA is 
sequestered by its repressor exsD while its activator exsC is inactivated by forming a 
heterodimeric complex with exsE. In contrast, under inducible conditions, exsE is secreted 
out of the bacterial cell through T3SS, which leaves exsC to interact with exsD and frees 











Figure I-5. Type III secretion system. a) 42 genes are identified in the type III secretion 
system. 36 genes are clustered together within a chromosomal region, encoded by five 
operons. 6 others are distributed elsewhere. b) The type III secretion system can be dissected 
into five components, needle complex, translocation apparatus, chaperones, regulatory 
proteins and effector proteins. c) The type III secretion system is activated or inactivated via 
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regulation of the master regulator ExsA by three other regulatory proteins, ExsC, ExsE and 
ExsD. Figure is adapted and modified from the reference Hauser 2009. 
1.6.4 Effector proteins 
As the four effector proteins (ExoS, ExoT, ExoY and ExoU) are directly translocated into the 
host cell, understanding the cytotoxicity of these four effectors will be necessary to tackle the 
pathogenesis of P. aeruginosa (Figure I-6). 
 
Figure I-6. Schematic diagram of four effector proteins. S, secretion signal; CBD, 
chaperone binding domain; MLD, membrane localization domain; GAP, GTPase activating 
protein; ADPRT, ADP ribosyl transferase (ADPRT); PLA2, phospholipase A2; CF, cofactor 
binding site. Figure is modified from the reference Hauser 2009. 
ExoS 
ExoS is a protein with 453 amino acids. It consists of several functional motifs (Zhang et al. 
2007). The first 15 amino acids are thought to act as a secretion signal to direct ExoS into the 
TTSS needle complex. Amino acids 16-51 are the potential binding site for SpcS, a 
chaperone of exoS. Amino acids 52-72 are considered to be the membrane localization 
domain (MLD) to allow the attachment of exoS to the plasma membrane of the host cells 
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after translocation. Amino acids 96-233, identified as a GTPase activating protein domain 
(GAP), are found to affect the assembly of the host cell cytoskeleton through regulating its 
substrates such as the small GTPase Rho and Rac. The disruption of the cytoskeleton 
assembly within the host cell can lead to cell rounding due to cellular shape change. This 
rounding is assumed to weaken the activity of phagocytosis from the host cell as reduced 
internalization of P. aeruginosa within several cell types is observed. Amino acids 233-453 
are identified as the ADP ribosyl transferase domain (ADPRT) and the ADPRT activity 
requires the binding of a cofactor, the 14-3-3 protein (Ottmann et al. 2007). 14-3-3, which is 
produced by the eukaryotic host cells, is necessary for exoS to trigger several adverse effects 
on the host cell, such as induction of cell death, disruption of membrane trafficking, 
endocytosis and DNA synthesis (Pederson and Barbieri 1998; Barbieri et al. 2001; Fraylick 
et al. 2001; Rocha et al. 2003). Meanwhile, the recruitment of eukaryotic 14-3-3 as a cofactor 
may prevent the ADP ribosyl activity of P. aeruginosa towards its own proteins resulting in 
its self disruption. Clearly, domain dissection of ExoS shows it is a bifunctional toxin that 
can affect the normal function of the host cell through distinct pathways. 
ExoT 
ExoT is a protein with 457 amino acids that shares 76% sequence identity with ExoS. ExoT 
contains two domains: the amino-terminal GAP domain (amino acids 78-235) and the 
carboxyl-terminal ADPRT (amino acids 235-457). The function of the GAP domain in exoT 
seems to be quite similar to exoS with respect to the interference of cytoskeleton organization 
and inhibition of phagocytosis and cell migration (Cowell et al. 2000; Garrity-Ryan et al. 
2000). The GAP domain has also been observed to inhibit cytokinesis through inactivating 
Rho GTPase (Shafikhani and Engel 2006). In contrast to the similar function shared by the 
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GAP domains of both ExoS and ExoT, the ADPRT domain in ExoT has different and limited 
protein targets in the host cell. ExoT is found to specifically alter the activity of CT10 
regulator of kinase (CRK) І and CRK II (Sun and Barbieri 2003), causing the inhibition of 
cytokinesis and blockage of signaling to RAC1 (Deng et al. 2005; Shafikhani and Engel 
2006). Like ExoS, ExoT is also a bifunctional toxin and can inhibit the phagocytosis and 
cytokinesis of the host cell, and this inhibition facilitates the invasion of P. aeruginosa into 
the host cell and hence its survival. 
ExoY 
ExoY is a protein with 378 amino acids. It has been identified as an adenylyl cyclase, with 
two domains similar to the domains of other adenylyl cyclases such as edema factor and 
CyaA (Yahr et al. 1998). These two domains act in concert to bind ATP. Injection of exoY 
into the mammalian cell can lead to an intracellular increase of cAMP and the expression of 
many different genes regulated by cAMP. Upregulation of these gene expressions can 
interfere with the function of actin cytoskeleton assembly (Yahr et al. 1998) and increase the 
endothelial permeability (Sayner et al. 2004). Therefore, it is conceivable that exoY, in 
synergy with exoS and exoT, will make the host more vulnerable to the infections caused by 
P. aeruginosa.  
ExoU 
ExoU is a 687-amino acid protein with strong phospholipase activity towards a wide range of 
substrates, such as phospholipids, neutral lipids, and lysophospholipids (Sitkiewicz et al. 
2007). It contains the binding site for chaperone spcU within residues 3-123 (Finck-
Barbancon et al. 1998), a phospholipase domain within residues 107-357 (Phillips et al. 
2003; Sato et al. 2003), and a C terminal region with no recognizable domains but has been 
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reported to be important for killing the host cell (Sato et al. 2003). ExoU is highly cytotoxic 
and can induce rapid host cell death. This rapid cell death induction may be closely 
associated with the finding that once ExoU is translocated into the host cell, it will bind to the 
membrane instantly, which might be through the recognition of its phospholipid substrate 
within the membrane that leads to an increase of the permeability of the membrane (Rabin et 
al. 2006).  However, unlike cell death induced by ExoS and ExoT, this type of cell death is 
characterized by an increased disruption of plasma membrane integrity, which more 
resembles necrosis (Finck-Barbancon et al. 1997). As expected, it is found that up to 90% 
cases of serious human P. aeruginosa infections can be attrituted to ExoU (Engel 2003). 
Hence, blockage of exoU translocation into the host cell could have a therapeutic effect 
against infections caused by P. aeruginosa. 
  Given the important pathogenic roles of TTSS and its effector proteins, identification of 
TTSS modulators will become a hot research topic as the modulators of this system will have 
the potential to become new drug targets. However, to date, only a limited number of TTSS 
modulators have been reported.  
1.6.5 Polyamine transport    
  Despite extensive studies of polyamine transport in E. coli, limited studies of polyamine 
transport in P. aeruginosa have been reported. One gene cluster of spuABCDEFGH in P. 
aeruginosa PAO1 was identified by Lu and coworkers (2002). In this report, the authors 
proposed that spuDEFGH is a spermidine transport ABC system based on phenotypes 
observed from gene knock-outs. Moreover, they found that polyamines could “induce 
resistance to cationic peptide, aminoglycoside, and quinolone antibiotics in Pseudomonas 
aeruginosa PAO1” (Kwon and Lu 2006). Recently, Zhou et al. (2007) found that the 
 27 
polyamine transport pathway is closely associated with the expression of nearly all TTSS 
genes. In this study, it was found that deletion of spuE or spuEFGH, which is the purported 
polyamine transport system in P. aeruginosa, downregulated 34 of the 36 genes from the 
clustered five operons by more than 2 folds, and the remaining two by around 1.6 folds. 
Moreover, three TTSS effector genes, ExoT, ExoY, and ExoS were downregulated by 7.5-, 
4.8- and 8.3-fold, respectively. Although exoU was not reported, this might be due to the 
absence of ExoU in the experimental P. aeruginosa strain because it had been observed that 
very few isolates contained all four effector proteins (Frank 1997). Thus, it is highly possible 
that polyamine transport pathway also regulates ExoU activity for isolates that express exoU. 
This global downregulation of TTSS expression indicates that polyamine transport system 
could specifically regulate TTSS activity. Consequently, the polyamine transport system in 
P. aeruginosa may become a new drug target against infections caused by this strain given 
the link between polyamine with TTSS and antibiotic resistance.  
Section 1.7 Rationale and aims 
Limited studies are available to address polyamine transport in P. aeruginosa. Several 
unresolved issues exist including: 
• SpuD and spuE are supposed to be spermidine binding proteins in P. aeruginosa 
based on the phenotypes of gene knock-outs, however, no direct evidence is available 
to confirm that spuD and spuE can indeed bind polyamine.  
•  SpuE or spuEFGH are found to be involved in the TTSS gene regulation, however, 
the role of spuD that plays in the regulation of TTSS gene expression has not been 
defined. 
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• The mechanism for polyamine recognition is still not clear although the structures of 
spermidine-bound potD and putrescine-bound potF have been solved. This 
uncertainty may be largely due to the lack of ligand-free structures as the structures of 
spermidine-bound potD and putrescine-bound potF are very similar. 
•  In many cases, a protein conformation will switch from an open to a closed form 
upon ligand binding. However, it is not known if this can be applied to spuD and 
spuE since their structures in both apo- and ligand-bound forms are not available.  
  The aims of this study were to: 
• study the role of spuD in the regulation of T3SS gene expression. 
• examine the binding between the protein (spuD and spuE) and the ligand (putrescine, 
spermidine and spermine) by isothermal titration calorimetry (ITC) as this approach 
can yield crucial thermodynamic information. 
• solve the structures of spuD and spuE in both apo- and ligand-bound forms by X-ray 
crystallography.  
• delineate the mechanism of ligand binding specificity and affinity based on the 
structures. 
• study the ligand-induced conformational changes based on the structures. 
  The results of this study may have the significance in the following aspects: 
• elucidation of the mechanisms for putrescine and spermidine recognition and 
identification of the structural determinants for the ligand induced conformational 
changes 
• providing important preliminary information for the structure-based drug design 
against the polyamine transport system in the P. aeruginosa 
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Chapter 2 Materials and Methods 
2.1 Experimental materials 
2.1.1 Strains  
E.coli BL21 star (DE3)        Invitrogen  
E.coli BL21 star (DE3) RIL Invitrogen  
E.coli DH5α                          Invitrogen  
2.1.2 Media  
LB           5 g Bacto-yeast extract, 10 g Bacto-trypton, 10 g NaCl (1L)  
LB agar   liquid LB medium supplemented with 1.5% Agar  
2.1.3 Protein expression vector  
 




Oligonucleotides were ordered from Proligo and Research Biolabs.  









B) Oligonucleotides for reverse-transcription PCR (Work from ZLH’s lab) 
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exsC-F    TATCGGTTTGCCTTCCCTGT 
exsC-R    TGATCGAGCAGATTGGCCAA 
popB-F   CGAGGGATGTCGAGAGTCTG 
popB-R   CGCCGACGATGATCGAAGCT 
pscF-F    GCAGATATTCAACCCCAACC 
pscF-R    GATCTTCTGCAGGATGCCTT 
pscQ-F   TGCAACTGGCCTTGCTGGAG 
pscQ-R  GTTGGCGAGGATGCGCACTT 
16s rRNA gene was used as control. 
2.1.5 Enzymes  
Pfu DNA polymerase    Stratagene  
PreScission protease     Amersham Biosciences  
Restriction enzymes      New England Biolabs 
2.1.6 Kits  
DNeasy Tissue Kit QIAGEN  
RNeasy Mini Kit QIAGEN  
ProSTAR Ultra HF RT-PCR system Stratagen  
QIAprep spin Miniprep Kit      QIAGEN  
QIAquick Gel Extraction Kit    QIAGEN  
QIAquick PCR purification Kit QIAGEN  
Coomassie Protein Assay Kit     PIERCE 
Site-Directed Mutagenesis Kit   QIAGEN 
2.1.7 Chromatography Columns  
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Glutathione Sepharose 4B  
HiPrep Desalting Column  
Hiload Superdex-75 26/60  
Hiload Superdex-200 26/60  
All Columns were purchased from GE Healthcare. 
2.1.8 Crystallization kits and tools 
 
NeXtal DWBlock AmSO4 Suite               QIAGEN 
NeXtal DWBlock Anions Suite                QIAGEN 
NeXtal DWBlock Cations Suite                 QIAGEN 
NeXtal DWBlock Classics Suite I-II            QIAGEN 
NeXtal DWBlock Classics L Suite            QIAGEN 
NeXtal DWBlock ComPAS Suite              QIAGEN 
NeXtal DWBlock Cryos Suite                    QIAGEN 
NeXtal DWBlock JCSG Core Suite I- IV        QIAGEN 
NeXtal DWBlock JCSG+ Suite                    QIAGEN 
NeXtal DWBlock MbClass Suite I-II            QIAGEN 
NeXtal DWBlock MPD Suite                       QIAGEN 
NeXtal DWBlock Nucleix Suite                  QIAGEN 
NeXtal DWBlock PACT Suite                     QIAGEN 
NeXtal DWBlock PEGs Suite I-II                   QIAGEN 
NeXtal DWBlock pHClear I-II Suite               QIAGEN 
NeXtal DWBlock ProComplex Suite              QIAGEN 
ADDITIVE SCREEN                                      Hampton Research 
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Wizard I- II                                                     Emerald Biostructures 
Crystallization tools                                         Hampton Research 
 
2.1.9 Buffers  
DNA electrophoresis and Protein SDS-PAGE (Laemmli 1970)  
DNA electrophoresis Buffer     40 mM Tris, 1.14% acetic acid, 1mM ethylene 
            diamine tetra acetic acid (EDTA) 
SDS-PAGE running Buffer              25 mM Tris base, 192 mM glycine, 0.1% (w/v)  
             sodium dodecyl sulfate (SDS)  
SDS-PAGE Staining Buffer             0.025% Coomassie Brilliant Blue R-250 
             30% Methanol, 10% Acetic Acid 
SDS-PAGE Destaining Buffer  30% Methanol, 10% Acetic Acid 
Protein purification 
Cell Lysis Buffer  20 mM Tris-HCl, pH 8.0, 500 mM NaCl,  
3mM dithiothreitol (DTT), Roche EDTA free 
protease inhibitor tablet 
Elution Buffer 20 mM Tris-HCl, pH 8.0, 500 mM NaCl,3mM 
dithiothreitol (DTT), 20 mM reduced  
Glutathione 
Desalting Buffer 20 mM Tris-HCl, pH 8.0, 100 mM NaCl,3mM 
dithiothreitol (DTT) 





100 bp DNA ladders   New England Biolabs 
1 kb DNA ladders New England Biolabs 
2-log DNA ladders  New England Biolabs 
Prestained protein markers  New England Biolabs 
IPTG  Invitrogen 
30% Acrylamide/Bis solution (29:1)  Bio-Rad 
2-Methyl-2, 4-pentanediol (MPD)  Hampton Research 
Polyethylene Glycol 400  Hampton Research 
Polyethylene Glycol 3350  Hampton Research 
Ethylene Glycol (EG)  Hampton Research 
Nuclease-free Water  Ambion 
 
 




2.1.11 Instruments and Facilities 
ND-1000 Spectrophotometer   NanoDrop 
Institute in-house DNA sequencing facility  
ÄKTA HPLC system  Amersham Biosciences 
Jasco J-810 Circular Dichroism Spectrapolarimeter  Jasco (ZLH lab) 
Phoenix liquid handling robot Rigaku 
In-house FRE X-ray generator  Rigaku 
Synchrotron beam lines  
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2.2 Gene cloning and protein expression 
2.2.1 Genomic DNA extraction from P. aeruginosa PAO1                                  
Pseudomonas aeruginosa PAO1 strain was inoculated into the LB media for overnight 
culture at 37°C. Cells were harvested and genomic DNA was extracted with DNeasy Tissue 
Kit and precipitated in ethanol. DNA was air-dried and dissolved in buffer (10 mM Tris-HCl, 
pH 7.5, 1 mM EDTA) in aliquots for storage at -20°C. 
2.2.2 Gene knock-out and growth conditions (Done by ZLH’s lab) 
P. aeruginosa PAO1 was used as a parental strain for generation of PAO1pClacZ reporter 
strain (Zhou et al. 2007). Under the background of PAO1pClacZ, spuD and/or spuE gene(s) 
were deleted either as single or double deletion using method as described by Dong et al. 
2008. For ∆spuD, a 886-nt coding region (from 27 - 912 bp) was deleted; for ∆spuE, it was 
the same construct  as in Zhou et al., (2007); for double deletion of spuD and spuE, the same 
region of ∆spuD was deleted in the background of  ∆spuE.  
  Bacteria were routinely grown at 37°C in Luria-Bertani broth (LB) or LB medium 
supplemented with the chelating reagent nitrilotiracetic acid (NTA) at a final concentration of 
5 mM to induce T3SS gene expression. 
2.2.3 Total RNA extraction from Pseudomonas aeruginosa PAO1  
RNeasy Mini Kit was used to extract total RNA. Purified RNAs were treated with DNase I 
and stored in RNase-free distilled water. The quantity and quality of RNA was examined by 
electrophoresis and UV260/280 absorption (NanoDrop).                             
2.2.4 Reverse Transcription (Done by ZLH’s lab) 
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The reverse transcription reaction was carried out using Pseudomonas aeruginosa PAO1 
total RNA with ProSTAR Ultra HF RT-PCR system (Stratagene). The reaction was heated 
to 65°C for 5 minutes to inactivate the DNase I in the RNA sample prior to incubation at 42 
°C for 30 minutes. First strand cDNA was stored in aliquots at -20°C. 
2.2.5 β-Galactosidase assay (Done by ZLH’s lab) 
β-Galactosidase activity was measured as described by Sambrook et al. (1987) by using P. 
aeruginosa reporter strains based on PAO1pClacZ. The reporter strains were grown at 37°C 
in LB or LB medium supplementing with NTA. Results are averages from four repeats and 
given as Miller units of β-galactosidase activity per OD600.  
2.2.6 PCR 
 General Reaction 
 Genomic DNA, 1st strand cDNA  1 μl 
 
Primers Forward and Reverse Primer each (10 μM)  1 μl  
 
Buffer 10X Pfu buffer  5 μl 
 
dNTPs 25 mM each of dATP, dCTP, dGTP, dTTP  1 μl 
 
Enzyme Pfu turbo DNA polymerase (2.5 U/ μl) 1 μl 
 
  Water    Double-distilled water  to volume of 50 μl 
 

























Enzyme Pfu turbo DNA polymerase (2.5 U/ μl) 1 μl 
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Add volume to 50  μl 
 
PCR Programs 
 General program 
 
94°C 3 minutes, 1 cycle; 94°C 30 seconds, 55°C  
 
 
45 seconds, 72°C 2 minutes, 35 cycles; 72 °C 10  
 
minutes, 1 cycle 
 














95°C 30 seconds, 1 cycle; 95°C 30 seconds, 55°C 1 
 
 minute, 68°C 1 minute / kilo base of plasmid length, 
 
for 20 cycles 
 
2.2.7 Purification of PCR products from agarose gel 
PCR products were loaded and run on 1.2% agarose gel. The PCR fragments with correct 
size were then excised and purified using QIAquick Gel Extraction Kit.   
2.2.8 Restriction Enzyme digestion of PCR products and plasmid 
































Digestion condition: 37°C for 3 hours.  
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Digested PCR products were purified using QIAquick PCR purification Kit, while digested 
vectors were purified using QIAquick Gel Extraction Kit. 
2.2.9 Ligation 
Ligation reaction (volume 15 μl) 
Ligation reaction was conducted at room termperature for 3 hours. 
Buffer 
 























5 μl of ligation products were added into 100 μl competent cell DH5α, which was put on ice. 
After 5 minutes, the competent cell containing the ligation products were subjected to heat 
shock at 42°C for 90 seconds and incubated in ice for a few minutes. After incubation, 400 μl 
LB were added inside and gently rotated in shaker at 37°C for 45 minutes. 200 μl were 
transferred to the agar plate containing 100 μg Ampicilin and spread evenly. The agar plate 
was incubated at 37°C incubator for 12 hours. 
2.2.11 Positive clone screening and plasmid preparation 
Four clones were picked up and inoculated into 3 ml LB containing appropriate antibiotics to 
grow overnight at 37°C shaker. Clones were screened by colony PCR. Plasmids from 
positive colonies were extracted using QIAprep Spin Miniprep kit and submitted for 
sequencing. 
2.2.12 DNA sequencing 
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DNA sequencing was conducted in in-house DNA sequencing facility. DNA sequencing 
components were described as below. 

















2.2.13 Expression test 
 
The plasmids after sequencing confirmation were transformed into the expression 
strain E.coli BL21 star (DE3). Two colonies from the expression strain were 
inoculated into 3 ml LB with appropriate antibiotics and grew overnight at 37°C 
shaker. 500 μl of cells were stored in 50% glycerol at -80°C. For expression test, 
100μl of cells was transferred into 10 ml of fresh LB medium and cultured at 37°C. 
When the optical density at OD600 reached about 0.5-0.6, 0.5 mM of Isopropyl-ß-
Dthiogalactopyranosid (IPTG) was added to induce gene expression for an 
additional 3 hours at 37°C. 100μl of cells were pelleted and boiled in SDS-PAGE 
loading buffer. The samples were separated by SDS-PAGE using a 12% 
polyacrylamide gel. 
2.3 Protein purification 
Note: all steps of protein purification were done at 4°C. All samples were filtered with 0.22 
µm filter before running on columns at FPLC systems.   
2.3.1 Protein expression in large-scale cell culture 
 
The expression strains were inoculated into 100 ml of LB medium containing the 
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appropriate antibiotics at 37°C overnight. 60 ml of cell culture was added into 6 L of LB 
medium and incubated in shaker with 200rpm at 37°C. When OD600 reached at 0.5-0.6, 
protein expression was induced by addition of IPTG to a final concentration of 0.1 mM at 
18°C overnight. The cell pellets were harvested by centrifugation and stored at -80°C for 
protein purification.  
2.3.2 Protein purification procedures 
 
2.3.2.1 Cell lysis 
 
Frozen cell pellets from -80°C were re-suspended in the lysis buffer containing 1mg/ml Hen 
egg Lysozyme. Loosened cells after Lysozyme digestion were disrupted by sonication with 
10 cycles of 15-second on and 90-second off using a Soniprep 150 (SANYO). The resulting 
crude extract was centrifuged for 1 hour at 18000 rpm (Beckman Coulter). The supernatant 
was mixed with Glutathione Sepharose 4B beads (Amersham) equilibrated with the cell lysis 
buffer. 
2.3.2.2 First GST affinity column chromatography 
 
After incubation with the Glutathione Sepharose 4B beads for 1 hour at 4°C, the beads were 
harvested by centrifugation at 1200rpm for 10 minutes. After extensive wash to remove non-
specific binding proteins to beads, GST-fusion proteins were eluted by 10-20 ml elution 
buffer. Protein yields were determined by the Bradford method using the Coomassie Protein 
Assay kit (Pierce) with BSA as a standard. PreScission protease (Amersham) was added at a 
ratio of 50:1 (w/w) to cleave the GST tag off the fusion proteins. The reaction mixture was 
gently rotated at 4°C overnight. 
2.3.2.3 Second GST affinity column chromatography 
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After digestion by PreScission protease, samples were loaded onto a HiPrep desalting 
column equilibrated by the desalting buffer. The desalted samples were passed through a 
regenerated Glutathione Sepharose 4B column to remove the cleaved GST tag and non-
cleaved GST-fusion proteins. The flow through was checked by SDS-PAGE.  
2.3.2.4 Gel filtration chromatography 
 
After the second GST affinity chromatography, the flow through was loaded onto gel 
filtration column Superdex-75 or Superdex-200 (Amersham) pre-equilibrated in the gel 
filtration buffers. The peak fractions were assessed using SDS-PAGE and the corresponding 
peak fractions with high purity were pooled together. The amount of proteins was estimated 
by the Bradford method and then concentrated in vivaspin 20 concentrators (5,000 MWCO, 
Vivascience) to 30 mg/ml. 
2.3.2.5 Analysis of polyamines by reverse phase-high pressure liquid chromatography 
(RP-HPLC) (Conducted by ZLH lab) 
Sample Preparation In this study, 75μl perchloric acid was added to 25μl protein solution to 
extract potential polyamines. Half of the mixture (50μl) was mixed with 150μl saturated 
sodium bicarbonate and 50μl dansyl chloride in acetone (9 mg/ml) (Kabra et al. 1986). The 
sample was incubated at 55°C for 1 hour. After the sample was cooled down to room 
temperature, 500μl toluene was added to extract the polyamines’ derivatives. 100μl of the 
toluene solution was mixed with 100μl methanol and filtered through 0.2 μm filter to prepare 
samples for RP-HPLC analysis. 
RP-HPLC analysis RP-HPLC analysis was performed using a Waters 2695 system and 
monitored by a 996 PDA and a 2475 fluorescence detector. Separation was performed on a 
reverse-phase column (Phenomenex, Luna 5μ C18 250*4.6 mm) with gradient program and 
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peaks were monitored by PDA detector with λ = 350 nm and fluorescence detector with λ = 
520 nm. The gradient progam was (MeOH in H2O): 55% (0 minute), 55%-65% (0-7 
minutes), 65% (7-14 minutes), 65%-70% (14-18 minutes),70%-75% (18-20 minutes), 75%-
80% (20-22 minutes), 80%-100% (22-27 minutes), 100% (27-35minutes), 100%-55% (35-36 
minutes), 55% (36-40 minutes).  
2.3.2.6 Preparation of ligand-free protein samples 
Purified and concentrated spuD and spuE were dissolved into 8M urea and loaded into 
desalting column (Amersham Biosciences) equilibrated by 8M urea. After desalting, spuD 
and spuE were loaded into gel filtration column (Amersham Biosciences) equilibrated by the 
gel filtration buffer for on column refolding. The flow rate of gel filtration was set at 2 
ml/min. The final concentration for crystallization of ligand-free spuD (hereinafter termed as 
apo-spuD) and ligand-free spuE (hereinafter termed as apo-spuE) was 30 mg/ml and 
20mg/ml respectively. RP-HPLC analysis showed that the ligands for both spuD and SpuE 
have been successfully removed (see below).  
2.4 Circular Dichroism 
The circular dichroism (CD) spectra were measured on a Jasco J-810 Circular Dichroism 
spectra-polarimeter at the wavelength ranging from 195 to 260 nm at a resolution of 0.1 nm. 
SpuD and spuE in apo- and ligand-bound states were exchanged into 25 mM Na/K phosphate 
pH 7.5 at the concentration of 25 μM and were transferred to a cell of 0.1cm path length. 
Three measurements were averaged for each sample and the molar ellipticity was calculated.  
2.5 Isothermal titration calorimetry (ITC) 
Isothermal titration calorimetry (ITC) measurements of protein (spuD and spuE) and ligand 
(putrescine and spermidine) were performed at 22°C in a VP-ITC microcalorimeter 
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(MicroCal Inc.) while ITC measurements of protein (spuD and spuE) and spermine were 
conducted in a MicroCal iTC200 (MicroCal Inc.). Protein samples were exchanged by 
desalting to a solution containing 20mM Tris pH 7.4 and 100mM NaCl. The protein 
concentration (spuD and spuE) in cell was 20 μM, while the ligand concentration in syringe 
was 100–200 μM. In the VP-ITC microcalorimeter, titrations began with one 2 µl injection 
and subsequent twenty-eight 10 µl injections. In the MicroCal iTC200, titrations initiated 
from one 0.5 µl injection and followed by nineteen 2 µl injections. MicoOrigin 7.0 program 
was used for data analysis. Based on the solved ligand-bound structures of spuD and spuE 
(see below), one-site binding model was used for data fitting to obtain the parameters of Kd, 
ΔH, and stoichiometry (N).  
2.6 Crystallization 
Crystallization screening was performed using the sitting-drop vapor-diffusion method at 
15°C by mixing 200nl protein solution with 200nl reagent solution in 96-well plates using 
Phoenix liquid handling robot. Initial crystallization hits were optimized using hanging drop 
vapor diffusion method and seeding in combination with additive screening (Hampton). 
  All crystals grew in 1 ml of reservoir solution. For the apo-spuD, 1 µl of protein sample was 
mixed with 1 µl of 0.1 M Mes, 25% polyethylene glycol (PEG) 3350, pH 6.5. For the apo-
spuE, 1 µl of protein sample was mixed with 1 µl of 0.1 M Tris, 0.2 M MgCl2, 25% PEG 
3350, pH 8.5. For the putrescine-bound spuD in wild type and C236A mutant, 1 µl of protein 
sample was mixed with 1 µl of 0.1 M sodium acetate, 10 mM ZnCl2, 28% PEG 3350, pH 5.0. 
All crystals grew to 0.1 * 0.02 * 0.02 mm3 within one week.  
  Prior to freezing into liquid nitrogen, all crystals were transferred in serial steps to the 
corresponding cryoprotectant conditions. Crystals from apo-spuD were transferred to 0.1 M 
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Mes, 28% PEG 3350, 10% glycerol, pH 6.5. Crystals from apo-spuE were transferred to 0.1 
M Tris, 0.2 M MgCl2, 28% PEG 3350, 10% glycerol, pH 8.5. Crystals from spuD in complex 
with putrescine were transferred to the mother liquor containing 10% 2-Methyl-2, 4-
pentanediol (MPD), pH 5.0.  
2.7 Data collection, structure determination and refinement 
To study the mechanism of ligand recognition and ligand binding affinity of spuD and spuE, 
four structures, apo-spuD, putrescine-bound spuD, apo-spuE and spermidine-bound spuE, 
were solved (spermidine-bound spuE was solved by Siew choo Lim in our lab). In order 
to study the effect of disulfide bond upon ligand recognition, the structure of putrescine-
bound spuD with C236A mutation was also solved.  
2.7.1 Data collection 
Data for spuD in complex with putrescine were collected at the beamline ID23-1 (European 
Synchrotron Radiation Facility). Data for apo-spuD and apo-spuE were collected at local 
Rigaku Cu-Kα X-ray machine with a Rigaku R-axis IV++ imaging-plate detector. Data for 
apo-spuD, apo-spuE, putrescine-bound spuD in wild type and C236A mutation were 
integrated with the program of Mosflm (CCP4 package) (1994). All data were scaled and 
merged with the program of Scala (CCP4 package) (1994).  
2.7.2 Structure determination and refinement 
  SpuD consists of 367 amino acids with a 24-amino acid secretion signal peptide, while spuE 
is a 365-amino acid protein with a 25- amino acid secretion signal peptide. Regions for the 
crystallization of spuD and spuE were amino acids 25-367 and 26-365, respectively. 
Molecular replacement using PHASER in CCP4 package (1994) was carried out to find 
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initial solutions for apo-spuD, putrescine-bound spuD, putrescine-bound spuD with C236A 
and apo-spuE.  
   Crystals of spuD in apo and putrescine-bound forms belonged to P212121 space group. 
Three molecules were located in one asymmetric unit (ASU) of apo-spuD while two 
molecules were included in one ASU of putrescine-bound spuD (wild type and C236A 
mutation). To solve the putrescine-bound spuD, one whole chain of potF in E. coli was used 
as the search model (PDB code 1A99). The searches yielded two clear solutions 
corresponding to the two molecules in the ASU. Each molecule contained two structural 
domains and the electron density map of putrescine in each of the two molecules was clearly 
visible between the two structural domains. Model building in COOT (Emsley and Cowtan 
2004) and model refinement via restrained refinement in REFMAC5 (Murshudov et al. 1997) 
and simulated annealing in CNS (Brunger et al. 1998), were conducted iteratively. Water 
molecules were added using CNS (Brunger et al. 1998) where chemically reasonable. 
Criteria of water pick up include peaks are above 2.5 sigma units, and the minimum and 
maximum hydrogen bonding distance between water and oxygen or nitrogen atom is 2.0 Å 
and 3.2 Å, respectively. The final model had an R-work of 21.1%, an R-free of 25.5% for the 
putrescine-bound wild-type spuD and an R-work of 20.4%, an R-free of 23.7% for the 
putrescine-bound spuD C236A (shown in Table 1).  
  To solve apo-spuD, the two individual domains from the putrescine-bound wild-type spuD, 
the amino-terminal (N) domain including residues 26-132 and 276-322, and the carboxyl-
terminal (C) domain including residues 133-275 and 342-366 were used as the search models 
as one whole chain from the putrescine-bound spuD as the search model failed to yield a 
reliable solution. Three clear solutions corresponding to each of the two individual domains 
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were identified. Combination of these solutions yielded three molecules in one ASU. The 
linker region of residues 323-341 in each molecule was confidently added based on the omit 
maps using coefficients 2Fo-Fc and Fo-Fc. Model refinement and water addition were 
similar to that of putrescine-bound spuD. An R-work of 21.9% and an R-free of 28.8% were 
obtained for the final model.  
  Apo-spuE was crystallized in P21 space group. Two molecules were located in one ASU. 
Similar to the solution of apo-spuD, two individual domains from spermidine-bound spuE, 
the N domain including residues 30-131 and 273-329, and the C domain including residues 
132-272 and 340-360 were used as the search models. Two clear solutions corresponding to 
each of the two individual domains were identified. Two molecules were built through the 
combination of these solutions. The linker region 330-339 in each molecule was traced 
clearly. After refinement and water addition, the final model had an R-work of 22% and an 













All final structures were geometrically checked using PROCHECK (Laskowski et al. 1993).  
In the final models, some residues were missing due to poor densities. They were Ala-25, 
Gly-366 and Lys-367 in each chain of apo-spuD, Ala-25 and Lys-367 in each chain of 
putrescine-bound spuD and putrescine-bound spuD with C236A, residues 26-27 and 363-365 
in each chain of apo-spuE, and residues 26-28, and 362-365 in each chain of spermidine-
bound spuE. In addition, residues 71-73 in chain A of spermidine-bound spuE were also 
disordered. Hence chain B in spermidine-bound spuE was more complete than chain A. 
Superposition showed that the root-mean-square-deviation (r.m.s.d.) of all Cα atoms among 
the two chains of putrescine-bound spuD, putrescine-bound spuD with C236A, apo-spuE and 
spermidine-bound spuE was 0.4 Å, 0.4 Å, 0.3 Å and 0.2 Å, respectively while the average of 
r.m.s.d of all Cα atoms among the three chains of apo-spuD was 0.77 Å (with range 0.6 Å-
1.0 Å). For the convenience of description and discussion, chain A from apo-spuD, 
putrescine-bound spuD and apo-spuE and chain B from spermidine-bound spuE were used 
below.  
2.8 Other methods for structure analysis 
Structures were superimposed using Top3D (CCP4 1994) and all structural figures were 
prepared using PyMol (http://www.pymol.org). Dali server was used for r.m.s.d. calculation 
(Holm et al. 2008). DynDom was used to identify domain boundary and hinge regions 
(Hayward and Berendsen 1998). Lsqkab (CCP4 package) was used for assessment of 
orientational changes between the N domain and C domain of ligand-free and ligand-bound 
structures when the N domain in both structures was superimposed as a reference.  
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Chapter 3 Results 
3.1 spuD and spuE in the regulation of T3SS (Done by ZLH). 
SpuDEFGH was supposed to be a spermidine transport ABC system in which spuDE are 
the periplasmic spermidine binding proteins (Lu et al. 2002). Zhou and coworkers (Zhou 
et al. 2007) found that knock out of spuE or spuEFGH in P. aeruginosa PAO1 
significantly down-regulates most of the T3SS gene expression. However the effect of 
spuD upon T3SS gene expression was not tested.  In order to examine the effect of spuD 
upon T3SS gene expression, a reporter system was used (Zhou et al. 2007) in which the 
LacZ reporter gene was fused to the promoter region of exsCBEA and integrated into the 
attB site of the P. aeruginosa PAO1 strain. Three knock-outs, spuD, spuE and spuDE 
were created and LacZ activity was monitored against exsA knock-out and wild type 
PAO1, the negative and positive controls respectively. The results (Figure I-7a) showed 
that the LacZ activity in spuD knock-out exhibited no obvious change compared to the 
activity in wild type PAO1. In contrast, the LacZ activity in spuE knock-out significantly 
decreased to the equivalent level of exsA knock-out. The LacZ activity in the double 
knock-out spuDE was equivalent to the single spuE knock-out. These results indicate that 
spuD has no regulatory role in the T3SS gene expression while spuE demonstrates a 
distinct role in the regulation of T3SS.  
  To further test our results, quantitative reverse transcription (RT)-PCR was used. Four 
genes: exsC, popB, pscF and pscQ were randomly chosen from four operons of T3SS. In 
agreement with our results from the LacZ reporter system, spuD knock-out showed no 
obvious effect on the expression of these four genes, while spuE knock-out significantly 
down-regulated the expression of these genes (Figure I-7c). The effect of spuE knock-
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out upon T3SS gene regulation further confirmed the findings by Zhou and coworkers 
(Zhou et al. 2007). All together, these data indicate that spuD is different from spuE in 
the regulation of T3SS genes in P. aeruginosa PAO1. 
 
 
Figure I-7. Roles of spuD and spuE on T3SS gene expression. a) Expression of LacZ gene 
under the promoter of exsCBAE in single or double mutants of ∆spuD and ∆spuE. β-
Galactosidase activity was measured in each mutant grown in LB or LB medium 
supplementing with NTA. Parent strain of PAO1pClacZ was used as positive control and 
exsA mutant was used as negative control. The results were averages from four repeats and 
given as Miller units of β-galactosidase activity per OD600. b) Locations of genes in operons 
for RT-PCR analysis were shown in red and bold. c) RT-PCR analysis of the expression of 




3.2 Protein purification 
After the first and second GST affinity column chromatography, samples (spuE, spuD of 
wild type and C236A mutant) were loaded onto gel filtration column for further purification. 
Gel filtration profiles and SDS-PAGE for the peaks of these samples were shown in Figure 
I-8, Figure I-9, Figure I-10.  
 
 
Figure I-8. Purification of spuD in complex with putrescine. a) spuD in complex with 
putrescine is eluted as monomer (peak position 180.80 ml) from the gel filtration column S75 
26/60. b) SDS-PAGE shows the purity of protein from the peak fraction. 
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Figure I-9. Purification of spuD-C236A mutant in complex with putrescine. a) spuD-
C236A in complex with putrescine is eluted as monomer (peak position 245.4 ml) from the 
gel filtration column S200 26/60. b) SDS-PAGE shows the purity of protein from the peak 
fraction. 
 
Figure I-10. Purification of spuE in complex with spermidine. a) spuE in complex with 
spermidine is eluted as two peaks from the gel filtration column S75 26/60. The first peak 
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corresponds to the void volume at 117.1 ml, while the second peak (177 ml) is the monomer 
position of spuE in complex with spermidine. b) SDS-PAGE shows the purity of protein 
from the second peak. 
Apo-spuD and apo-spuE were prepared as described at methods section 2.3.2.6. Gel filtration 
profiles and purity of the samples checked with SDS-PAGE were shown in Figure I-11 and 
Figure I-12. The majority of eluted spuD corresponded to the position of ligand-bound spuD 
(see comparison with Figure I-8). In contrast, only a small portion of spuE after refolding 
eluted at the corresponding position of the spuE-spermidine as in Figure I-10, while most of 
the spuE was found in the void volume (Figure I-12). This indicates that the majority of 
spuD and a small fraction of spuE were refolded properly. 
 
Figure I-11. Purification of apo-spuD. a) ligand-free spuD is eluted as monomer (peak 
position 177.80 ml) from the gel filtration column S75 26/60. b) SDS-PAGE shows the 
purity of protein from the peak fraction. 
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Figure I-12. Purification of apo-spuE. a) ligand-free spuE is eluted as two peaks (the first 
peak at 117.3 ml for the void volume and the second peak at 177.1 ml for the monomer spuE) 
from the gel filtration column S75 26/60. b) SDS-PAGE shows the purity of protein from the 
second peak fraction. 
  In order to test if spuD and spuE after urea treatment are well folded, circular dichroism 
(CD) analysis was used to compare the spectra of spuD and spuE before and after urea 
treatment. As shown in Figure I-13, the CD spectra of spuD in apo- and putrescine-bound 
states showed quite similar pattern. Also, the CD spectra of spuE in apo- and spermidine-
bound states were close to each other. In agreement with the elution behavior observed from 
the gel filtration chromatography after on column refolding, these data further support that 








Figure I-13. Comparison of CD spectra of spuD and spuE in apo- and ligand-bound 
states. a) Overlay of CD spectra between ligand-free and putrescine-bound spuD. b) Overlay 





3.3 spuD is a putrescine binding protein while spuE is a spermidine binding protein. 
To determine the polyamine binding property of spuD and spuE, we expressed and 
purified spuD and spuE, followed by using ITC to test their binding affinity towards 
putrescine, spermidine and spermine. To our surprise, spuD and spuE showed no binding 
towards all these tested polyamines (data not shown) which is in conflict with the 
previous report (Lu et al. 2002) that spuD and spuE are supposed to be spermidine 
binding proteins. One possibility is that spuD and spuE have already been loaded with 
some ligands during the process of protein purification and the ligand pre-loading blocks 
spuD and spuE to bind any additional ligands and therefore causes false negative results. 
In order to test this possibility, RP-HPLC was used and we found that spuD was clearly 
preloaded by putrescine and spuE by spermidine (Figure I-14).  
 
Figure I-14. Analysis of spuD and spuE with RP-HPLC. Four polyamine standards 
were used which include putrescine (1), cadaverine (2), spermidine (3) and spermine (4) 
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as labeled in the picture. The arrow indicates the presence and position of ligand released 
from spuD and spuE before urea denaturation. 
   To assess the ligand binding affinity, we prepared ligand-free spuD and spuE (see 
procedures in method for sample preparation), and repeated the ITC experiment. ITC data 
(Figure I-15) showed that SpuD bound to putrescine with high affinity (Kd = 3 nM) and to 
spermidine with low affinity (Kd = 6.8 μM). In contrast, spuE showed high binding affinity to 
spermidine (Kd = 14.3 nM) and no detectable binding to putrescine. Both proteins showed no 
binding to spermine. Despite the structural similarity between putrescine and spermidine, 
spuD and spuE can still recognize their respective ligand efficiently. These results underscore 
that spuD and spuE bind their each ligand with high specificity and high affinity and also 
argue that spuD may be a periplasmic putrescine binding protein while spuE is a periplasmic 









Figure I-15. Analysis of polyamine binding of spuD and spuE using ITC. A time course of 
power supply of each injection was shown in the upper panel of each part.  In the lower panel 
of each part, the generated heats from each injection were shown in circles and fitted by one 
site model in continuous line. a) Binding between spuD and putrescine. b) Binding between 
spuE and spermidine. c) Binding between spuD and spermidine. d) Binding between spuE 
and putrescine. e) Binding between spuD and spermine. f) Binding between spuE and 
spermine. 
3.4 Crystallization, data collection and model refinement 





Figure I-16. Crystal pictures of spuD and spuE. a) ligand-free spuD. b) spuD in complex 
with putrescine. c) spuD-C236A in complex with putrescine. d) ligand-free spuE.  
  Data collection and model refinement of apo-spuD, spuD-putrescine and spuD-C236A-
putrescine is shown in Table 1. Data collection and model refinement of apo-spuE is shown 






Table 1. Data collection and refinement statistics of spuD in apo- and putrescine-bound 
forms.  
Data collection  apo spuD spuD-putrescine 
spuD-C236A-
putrescine 
Wavelength (Å) 1.5418 0.97988 0.97988 
Resolution (Å) 2.97(3.045-2.97) 2.0(2.052-2) 2.0(2.052-2) 
Space group P212121 P212121 P212121 
Cell parameters 
   a/b/c (Å) 47.8/109.0/228.5 65.9/82.9/128.3 66.0/83.0/128.2            
α/β/γ (°) 90/90/90 90/90/90 90/90/90 
Total reflections 76892 217313 569273 
Unique reflections (N) 21850 44053 48071 
I/σ 8.8 (2.3) 5.9 (5.6) 9.0 (6.3)                          
Completeness (%) 85.4 (80.1)             92 (63.5) 99.4 (98.8)                      
Rmerge (%)a 7.3 (32.9) 7.4 (12.2) 5.7 (11.6)                        
Refinement statistics 
   Data range (Å)  20-2.97                    69.67-2 69.67-2                     
Used reflections (N)              20613 41789 45588 
Nonhydrogen atoms              8157 5656 5668 
Water 133 284 298 
Rwork/Rfree (%)b           21.9/28.8 21.1/25.5 20.4/23.7                 
R.m.s. deviation 
   Bond length (Å) 0.007 0.01 0.007 
Bond angle (deg) 1.207 1.184 1.025 
Protein B factors (Å2) 40.0 17.6 13.8 
Water B factors (Å2) 32.4 20.2 17.6 
Ligand B factors (Å2)  --- 10.5 7.2 
Ramachandran plot (%)c 
   Most favored region 82.3 92.5 93.1 
Additionally allowed 
region 17 7.5 6.9 
Generously allowed 







Table 2. Data collection and refinement statistics of apo-spuE.  
Data collection  apo spuE 
Wavelength (Å) 1.5418 
Resolution (Å) 2.3(2.359-2.3) 
Space group P21 
Cell parameters 
 a/b/c (Å) 64.3/48.8/114.3 
α/β/γ (°) 90/103.2/90 
Total reflections (N) 205552 
Unique reflections (N) 30163 
I/σ 7.1 (4.2) 
Completeness (%) 96.8 (74.5) 
Rmerge (%)a 7.4 (17.2) 
Refinement statistics 
 Data range (Å)  20-2.3 
Used reflections (N)              28592 
Nonhydrogen atoms              5441 
Water 205 
Rwork/Rfree (%)b           22.0/27.0 
R.m.s. deviation 
 Bond length (Å) 0.011 
Bond angle (deg) 1.381 
Protein B factors (Å2) 30.8 
Water B factors (Å2) 30.8 
Ramachandran plot (%)c 
 Most favored region 91.7 
Additionally allowed region 8.1 
Generously allowed region 0.2 
 
Values in the highest resolution shell are shown in parentheses. 
a Rmerge = Σ|Ij-<I>|/ΣIj, where Ij is the intensity of an individual reflection, and <I> is the 
average intensity of that reflection. 
b Rwork =Σ||Fo| - |Fc|| / Σ|Fc|, where Fo denotes the observed structure amplitude, 
and Fc denotes the structure factor amplitude calculated from the model. Rfree is 
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calculated with 5.0% of randomly chosen reflections omitted from the refinement (Brunger 
1992). 
c Fractions of residues in most favoured/allowed/generously allowed/disallowed regions of 
the Ramachandran plot were calculated according to PROCHECK (Laskowski et al. 1993). 
3.5 Overall structure description 
  Structures of apo and putrescine-bound spuD belong to α/β type of proteins and consist of 
two similar globular domains, amino-terminal domain (N domain) and carboxyl-terminal 
domain (C domain), with 3 domain hinge segments (Figure I-17a, b and c). Each domain is 
composed of a centeral strands-mixed β sheet flanked by α helices at both sides. N domain 
contains amino acids 26-132 and 276-322 while C domain comprises amino acids 135-272 
and 342-366. The three domain hinge segments are segment I with amino acids 133-134, 
segment II with amino acids 273-275 and segment III with amino acids 323-341. Segment I 
and segment II are from a part of two anti-parallelled β strands and sandwiched by the N and 
C domain with low solvent accessibility. In contrast, segment III is composed of two short α 
helices and located at the surface of the two domains with high solvent accessibility. This 
suggests that segment III is more flexible than segment I and II. One disulfide bond between 
Cys-173 and Cys-236 was identified in both apo and putrescine-bound spuD. This disulfide 
bond is located at the beginning of two adjacent β strands within the C domain, which may 
stabilize the conformation of C domain. However, r.m.s.d. between the wild type and the 
mutant C236A of spuD is 0.13 Å. This shows that the disulfide bond is dispensable in 
maintaining the conformation of C domain and in ligand binding specificity although Cys-
171 and Cys-214 in spuE (the equivalents to Cys-173 and Cys-236 in spuD) fail to form a 
disulfide bond. 
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  Similar to the overall shape of spuD, spuE in apo and spermidine-bound structures are also 
composed of two globular domains, the N domain and the C domain (Figure I-17d and e) 
and three hinge segments between the two domains. Each domain consists of a centeral β 
sheet of mixed strands which are surrounded by α helices at both sides. The N domain 
comprises amino acids 30-131 and 273-329 while the C domain includes amino acids 134-
270 and 340-360. Three hinge segments are segment I with amino acids 132-133, segment II 
with amino acids 271-273 and segment III with amino acids 330-339. Segment I and II are 
from two anti-paralleled β strands and link the N domain and C domain closely. Segment III 
is composed of one short α helix and located at the surface of the two domains. R.m.s.d. of 
all Cα atoms between the apo-spuD and apo-spuE is 1.5 Å while r.m.s.d. between putrescine-
bound spuD and spermidine-bound spuE is 0.9 Å (Figure I-18a and b). Although the overall 
shape of spuD and spuE in apo and ligand-bound forms looks quite similar, close 
examination showed that ligand-bound spuD and spuE are more compact than apo-spuD and 
apo-spuE. This indicates that ligand binding induces a conformational change. 
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Figure I-17. Overall structures of apo- and ligand-bound spuD and spuE. The amino 
terminal domain (N domain) is shown in pale green; the carboxyl terminal domain (C 
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domain) is shown in pale yellow; the hinge regions are shown in light magenta. Ligand 
(putrescine and spermidine) is shown in stick model; the carbon atoms are orange, the 
nitrogen atoms are blue. Disulfide bond is shown in black line. a) apo spuD. b) wild type 
spuD in complex with putrescine. c) C236A spuD in complex with putrescine. d) apo spuE. 
e) spuE in complex with spermidine. 
 
  PotD and potF are polyamine receptors located in the E. coli periplasm. PotD shows 
preference to spermidine (Kd = 3.2 μM) and low affinity to putrescine (Kd = 100 μM) 
(Kashiwagi et al. 1993) , whereas potF only shows putrescine specific binding (Kd = 2.0 μM) 
(Vassylyev et al. 1998). Structure of potF in complex with putrescine is α/β type and consists 
of two globular domains with three linker segments between the two domains (Vassylyev et 
al. 1998). R.m.s.d. of all Cα atoms between putrescine-bound spuD and putrescine-potF 
(PDB code 1A99 chain A) was 0.97 Å (Figure I-18c). This indicates the overall structures of 
spuD and potF are similar. 
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Figure I-18. Superposition of Cα backbones from apo spuD (green), apo spuE (violet), 
spuD in complex with putrescine (red), spuE in complex with spermidine (cyan), potF 
in complex with putrescine (slate blue). Ligand (putrescine and spermidine) is shown as a 
stick model. a) apo spuD and apo spuE. b) spuD in complex with putrescine and spuE in 
complex with spermidine. c) spuD in complex with putrescine and potF in complex with 
putrescine.  
3.6 Ligand binding induces conformational changes 
It is believed that ligand induced protein conformational change, in most cases, if not all, 
switches between open and closed forms. The structures from apo and ligand-bound spuD 
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and spuE support this view. In spuD, one domain rotates 45.9° with respect to the other 
domain when compared between the apo and putrescine-bound structures. In spuE, the 
rotational angle of one domain with respect to the other domain is 38.8° between the apo and 
spermidine-bound structures (Figure I-19a and b). In contrast, the two domains in spuD and 
spuE show no translation upon ligand binding. Although, in spuD and spuE, rotation between 
the two domains upon ligand binding is obvious, however each of the two domains is quite 
rigid. The rigidity of the two domains after rotation can be reflected from the r.m.s.d. of 0.65 
Å between the N domains of apo and putrescine-bound spuD, and the r.m.s.d. of 0.90 Å 
between the C domains of apo and putrescine-bound spuD. Similarly, the r.m.s.d. between 
the N domains of apo and spermidine-bound spuE is 0.82 Å, and the r.m.s.d. for the C 
domains of apo and spermidine-bound spuE is 0.96 Å. The hinge region can be clearly 
identified through the superposition of apo and ligand-bound structures though single 
structure may give a rough estimation of the boundary of hinge region.  
  Spermidine-bound potD is closed by 43.6° compared with the apo-spuE open form, which 
is 4.8° more closed as compared to that of spermidine-bound spuE. Similarly, Putrescine-
bound potF is closed by 44.9° when compared with the apo-spuD open form, which is very 






   
Figure I-19. Stereoview of Cα backbone superpositions from apo spuD (green), spuD in 
complex with putrescine (red), apo spuE (violet), spuE in complex with spermidine 
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(cyan). Putrescine and spermidine are shown in stick models. The N domain in both spuD 
and spuE is fixed as the reference domain. a) Cα superposition of apo spuD and spuD in 
complex with putrescine. b) Cα superposition of apo spuE and spuE in complex with 
spermidine. 
 
  In addition to the global conformational changes induced upon ligand binding, examination 
of individual amino acid reveals that local changes occur largely within the three hinge 
segments. Connector I and II may be active in the ligand induced hinge motion, while 
connector III seems to be passive in the hinge motion as it is located at the surface of the two 
globular domains and distant from the ligand binding site. Changes of dihedral angle of 
ligand-free and ligand-bound spuD and spuE were shown in table 3.  
 
Table 3. Δφ and Δψ of connector I and II from spuD and spuE in ligand-free and 
ligand-bound structures. 





   
  Superposition of connector I and II from pairs of spuD and spuE in apo and ligand-bound 
forms shows different shifts among these corresponding hinge amino acids (Figure I-20). 
These differences may reflect the underlying ligand binding specificity for spuD and spuE. 
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Figure I-20. Stereo view and superposition of connector I and II from spuD and spuE in 
both ligand-free and ligand-bound structures. Amino acids are shown in stick models. 
Oxygen is shown in red; nitrogen is shown in blue. Carbon atoms in spuE are shown in 
green; carbon atoms in spuD are shown in cyan; carbon atoms in putrescine and spermidine 
are shown in orange.  a) apo spuD and apo spuE. b) putrescine-bound spuD and spermidine-
bound spuE. 
3.7 Putrescine binding site in spuD and comparison with potF 
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Putrescine is buried within a pocket formed by the N domain and C domain in spuD (Figure 
I-17b). The ligand is fastened in the pocket through hydrogen bonding and van der Waal 
interactions with amino acids from the N domain, C domain and hinge region (Figure I-21). 
In the inner side of the pocket, the N2 of putrescine establishes hydrogen bonds to the OD2 
of Asp-275 (2.78 Å) and water 4(S) (2.89 Å). This water is tethered by the OG of Ser-83 
(2.60 Å) from the N domain and the OE1 of Glu-183 (2.50 Å) from the C domain. At the 
other side (entry side) of the pocket, the main chain carboxyl oxygen atoms from Ser-36 
(2.84 Å) and Asp-37 (3.32 Å) in the N domain and the OD1 of Asp-244 (2.73 Å) in the C 
domain form hydrogen bonds with the N1 of putrescine directly. Water 51(S) makes 
hydrogen bond (2.85 Å) with the N1 and this water is tightened by the O and OG of Ser-36. 
Although water 32(S) forms weak hydrogen bond with the N1 (3.5 Å), it establishes a strong 
hydrogen bond (2.70 Å) with the 51(S), and it is further held in position by the O of Ser-223 
(2.70 Å) and the OD2 of Asp-244 (2.80 Å) from the C domain. These hydrogen bonds 
converge to lock the two ends of putrescine in position. 
  Besides the hydrogen bond interactions between putrescine and spuD, the hydrocarbon 
backbones of putrescine establish extensive van der Waal interactions with five aromatic 
acids from spuD, Trp-35, Tyr-38 and Phe-311 from the N domain, Tyr-241 from the C 
domain and Phe-273 from the linker region connector II (Figure I-21). All these polar and 
non-polar mediated interactions together contribute to the high binding affinity of spuD 
towards putrescine.  
  Comparison of the putrescine interaction between spuD and potF (PDB accession code 
1A99 chain A) shows that most hydrogen bonding and van der Waals are well conserved. 
Close examination of putrescine binding reveals a few variations (Figure I-22). Firstly, in 
 71 
spuD, the OE1 of Glu-183 establishes a strong hydrogen bond with the N2 of the putrescine 
through water 4(S) bridging. In contrast, the OE2 of Glu-185 in potF, the equivalent to Glu-
183 in spuD, makes a strong hydrogen bond with the N2 of putrescine through water 
bridging. On the other hand, the OE2 of Glu-183 in spuD is fastened by the OG of Ser-180 
and the OH of Tyr-241, whereas the OE1 of 185E in potF is tethered by the OG1 of Thr-138 
and the NE1 of Trp-244 (the equivalent to Tyr-241 in spuD). The observation that the 
different rotamers of the equivalent amino acid are involved in the ligand binding indicates 
that ligand binding is determined not only by the direct amino acids but also by the adjacent 
interaction surroundings of these amino acids. Secondly, the position of water 4(S) in spuD 
and the corresponding water in potF shows a shift compared to the position of the other two 
water 32(S) and 51(S) with their corresponding water in potF. This shift may be due to the 
different interaction surrounding of Glu-183 in spuD and Glu-185 in potF. Of note, these 
variations between spuD and potF are all from the N2 region (the inner side of the pocket) 
while the N1 region is more conserved (the entry side of the pocket).   
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Figure I-21. Putrescine binding sites in spuD. Ligand and amino acids involved in the  
ligand binding are shown as stick models. Water is shown as sphere. Oxygen and nitrogen 
are shown in red and blue respectively. The N domain, C domain and hinge regions are 
shown in the same color as in Figure I-17. Amino acids involved in ligand binding are 
shown in the same color as their domain distributions. Carbon atoms in putrescine are shown 









Figure I-22. Side by side comparison of putrescine binding sites between spuD and potF. 
Ligand and amino acids involved in the ligand binding are shown as stick models. Water is 
shown in sphere. Oxygen and nitrogen are shown in red and blue respectively. SpuD is 
shown in green while potF is shown in cyan. Carbon atoms in putrescine are shown in 
orange. 
3.8 Spermidine binding site in spuE 
 Similar to the spuD in complex with putrescine, spermidine is engulfed within a cleft formed 
by the N and C domains in spuE (Figure I-17e). Amino acids from the N domain, C domain 
and hinge region are involved in the ligand binding. 
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 N1, N2 and N3 of spermidine are found to establish hydrogen bonding interactions with the 
amino acids from the N domain, C domain and hinge region (Figure I-23). N1, like the N1 
of putrescine, refers to the entry site of the pocket, while N2 is located in the middle of the 
pocket and N3, the most inner side. The amino acids for hydrogen bonding with the N3 
include Asp-180, Glu-181, Asn-269 and Ser-343. Of note, these four amino acids are all from 
the C domain. The OE2 of Glu-181 (2.78 Å) and the ND2 of Asn-269 (2.80 Å) make direct 
hydrogen bonds with the N3 whereas the OD2 of Asp-180 (2.88 Å) and the OG of Ser-343 
(2.80 Å) establish hydrogen bonds with the N3 through water 119 (S) bridging (2.99 Å). In 
the middle of the pocket, the OD2 of Asp-273 from the hinge region connector II makes a 
hydrogen bond with the N2 of spermidine. In the entry site of the pocket, the O of Thr-35 
(2.94 Å) from the N domain, the OD1 (2.88 Å) and OD2 (3.13 Å) of Asp-242 from the C 
domain form direct hydrogen bonding with the N1 of spermidine, while the OG1 of Thr-35 
(2.65 Å), the OD2 of Asp-36 (3.16 Å) and the OD2 of Asp-242 (3.24 Å) establish hydrogen 
bonds with the N1 of spermidine through water 94(S) bridging (3.11 Å).   
  In addition to the hydrogen bonding of the three amino groups from spermidine to spuE, the 
hydrocarbon chains of spermidine are found to establish van der Waal interactions with four 
aromatic residues of spuE which are Trp-34, Tyr-37 from the N domain, Tyr- 239 from the C 
domain, and Trp-271 from the hinge region connector II (Figure I-23). 
   It is noted that more hydrogen bonding interactions are established within the two ends (N1 
and N3), while the middle portion (N2) only has one hydrogen bonding interaction. This 
might be a strategy of interaction between proteins and their linear ligands, with the two ends 
















Figure I-23. Spermidine binding sites in spuE. Ligand and amino acids involved in the 
ligand binding are shown as stick models. Water is shown as sphere. Oxygen and nitrogen 
are shown in red and blue respectively. The N domain, C domain and hinge regions are 
shown in the same color as in Figure I-17. Amino acids involved in ligand binding are 
shown in the same color as their domain distributions. Carbon atoms in spermidine are 






Chapter 4 Discussion 
Although the overall structures of spuD and spuE either in apo-or ligand-bound forms are 
quite similar, which can be reflected from their low r.m.s.d. and 59% sequence identity 
(Figure I-24), however, spuD and spuE exhibit sharply different ligand binding preferences. 
As the N1 and N2 of spermidine are corresponding to those of putrescine, we predict that the 
overlapping region between putrescine and spermidine may reflect a common feature for 
putrescine and spermidine binding, i.e. between the N1 and N2 while the key factors in 
determining ligand specificity of spuD and spuE possibly stem from the non-overlapping 
region, i.e. between the N2 and N3 of spermidine.  
  To test our prediction, we compare the four structures, apo-spuD, putrescine-bound spuD, 
apo-spuE and spermidine-bound spuE. Amino acids involved in aromatic stacking and 
hydrogen bonding with ligand in spuD and spuE are summarized in table 4. Several common 
























Figure I-24. Sequence alignments of polyamine binding proteins in bacteria. From top to 
bottom: spuD from Pseudomonas aeruginosa, spuE from Pseudomonas aeruginosa, potF 
from E.coli, potD from E.coli. The sequence alignment was obtained by CLUSTALW 
(Thompson et al. 1994), and the figure was generated by ESPrpit (Gouet et al. 1999). Strictly 
conserved amino acids were shown with white letters in red, amino acids with similartity 
scores > 0.7 were in red letters and amino acids with similarity scores < 0.7 were shown in 
black letters. Cysteines involved in disulfide bond were labelled as digit 1 in green. The 
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secondary structural elements of spuD wild type in complex with putrescine were generated 
by DSSP (Kabsch and Sander 1983) and labeled above the sequences. 
Table 4. Summary of amino acids involved in aromatic stacking and hydrogen bonding 
with ligand in spuD and spuE. 
 
Nitrogen atoms of 




N1 S36 T35 
S36 via water T35 via water 
D37 D36 via water 
D244 D242 
D244 via water D242 via water 
S223 via water s221 
N2 D275 D273 
S83 via water s82 
E183 via water  e181 
N3 e183 E181 
g271 N269 
t182 D180 via water 
f345 S343 via water 
Aromatic residues in 
van der Waals  
spuD spuE 
N domain W35 W34 
Y38 Y37 
F311 Y309 
Hinge region F273 W271 
C domain Y241 Y239 
Amino acids involved in interactions with ligand in spuD and spuE are shown in upper case 
while structurally equivalent amino acids but not involved in interactions with ligand are 




4.1 Common features between spuD and spuE in ligand binding  
First, residues from the hinge region, Phe-273 and Asp-275 in spuD and their equivalents 
Trp-271 and Asp-273 in spuE interact with their respective ligand by van der Waals and 
hydrogen bonding. These interactions highlight the role of hinge region played upon ligand 
binding and subsequently conformational change around the hinge axis. Second, residue Tyr-
38 from the N domain of spuD forms a strong hydrogen bond with the residue Asp-275 
located at the hinge, in both apo (2.71 Å) and putrescine-bound form (2.66 Å) (Fig. 6A and 
6B). Similarly, Tyr-37 from the N domain of spuE establishes a hydrogen bond to the hinge 
residue Asp-273 in both apo (2.50 Å) and spermidine-bound forms (2.57 Å). The hydrogen 
bonding interaction between domain and hinge region may be important in transducing the 
rotational signal from the hinge region to the domain and then coordinating domain 
movement upon ligand binding. In contrast, no amino acid from the C domain in both spuD 
and spuE is found to make hydrogen bonding to the hinge amino acid. This may indicate that 
the N domain interacts with the ligand earlier than the C domain due to the close link 
between the N domain and the hinge amino acid. Third, we notice that the distance between 
the CG of Tyr-38 and the CG of Asp-275 in apo-spuD (6.09 Å) and putrescine-bound spuD 
(6.30 Å) is close to the distance between the N1 and N2 of putrescine (5.95 Å) (Figure I-25a 
and b). Similarly, the distance between the CG of Tyr-37 and the CG of Asp-273 in apo-spuE 
(6.37 Å) and spermidine-bound spuD (6.37 Å) coincides well to the distance between the N1 
and N2 of spermidine (6.13 Å) (Figure I-25a and b). Thus it seems that Tyr-38/Asp-275 in 
spuD and Tyr-37/Asp-273 in spuE act as a ruler to identify the region between the N1 and 
N2 of putrescine and spermidine. In this ruler, Asp-275D in spuD and Asp-273D in spuE 
form a strong hydrogen bond to the N2 of putrescine and spermidine respectively, while Tyr-
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38 in spuD and Tyr-37 in spuE establish van der Waal interactions to hold the corresponding 
hydrocarbon atoms of putrescine and spermidine in place. Moreover, this correlation between 
the corresponding Tyr/Asp and the N1 and N2 of putrescine and spermidine is also observed 
in potD and potF (PDB code 1A99, 1POT, 1POY). Although the TpPotD is in complex with 
Mes (PDB code 2V84), the distance between the CG of Tyr-17 and the CG of Asp-240 
(equivalent to Tyr-38 and Asp-275 in spuD respectively) is 6.27 Å which is close to the 
distance from the corresponding amino acid residues in spuD, spuE, potD and potF. This 
further supports our proposal that the Tyr/Asp forms a ruler to recognize the region between 
the N1 and N2 of putrescine and spermidine. And this ruler may also explain the observation 
that spermidine binds to spuE in a unidirectional manner is due to the asymmetrical 
distribution of nitrogen atoms (N1, N2 and N3) in spermidine. 
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Figure I-25. Stereo view and superposition of amino acids from spuD and spuE to show 
the similarities and differences in ligand recognition. Amino acids are shown as stick 
models. Water is shown as sphere. Oxygen is shown in red; nitrogen is shown in blue. 
Carbon atoms in spuD are shown in cyan; carbon atoms in spuE are shown in green; carbon 
atoms in putrescine and spermidine are shown in orange. Distance between the N1 and N2 of 
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putrescine and between the CG of 38Y and CG of 275D in spuD is shown in dashed lines. a) 
apo-spuD and apo-spuE. b) putrescine-bound spuD and spermidine-bound spuE. 
 
All together, these common features may reflect a conserved mechanism for the recognition 
of linear ligands such as polyamines. As suggested by Vassylyev and coworkers (Vassylyev 
et al. 1998), the N domain moves earlier than the C domain upon ligand binding based on the 
observation that more amino acids from the N domain in potF are involved in ligand binding. 
Based on this assumption, we further propose that polyamine binding proteins may undergo 
three steps of conformational change upon ligand binding. Polyamine is first recognized by 
the hinge amino acids and the N domain then moves towards the ligand due to the hydrogen 
bonding connection between the N domain and the hinge amino acid. The rotational change 
of the hinge region and movement of the N domain during this process induces the shift of 
the C domain towards the ligand, burying it between the two domains. Also, we suppose that 
the interaction between the N domain and the hinge amino acids may be the reason to address 
that more amino acids from the N domain are involved in the ligand binding. 
4.2 Differences between spuD and spuE in ligand binding 
Despite the common features shared by spuD and spuE in ligand binding, our ITC studies 
clearly reflect that the two proteins have different ligand binding specificities. Structural 
comparison of ligand-free and ligand-bound forms between spuD and spuE reveals several 
notable differences within the non-overlapping region of putrescine and spermidine, i.e. 
between the N2 and N3 of spermidine. First, the OD1 of the hinge amino acid Asp-275 in 
apo-spuD establishes a hydrogen bond to the OG of Ser-83 (2.57 Å), and this hydrogen bond 
is maintained in the form of putrescine-bound spuD (2.58 Å). In contrast, Asp-273 in apo-
 83 
spuE (the equivalent to Asp-275 in spuD) is 4.57 Å away from Ser-82 (the equivalent to Ser-
83 in spuD), but a hydrogen bond (2.71 Å) between Asp-273 and Ser-82 is induced upon 
spermidine binding (Figure I-25a and b). Second, besides hydrogen bonding interaction 
between Ser-83 and Asp-275 in spuD, Ser-83 also hydrogen bonds to the Asn-63 in both apo 
(3.03 Å) and putrescine-bound (2.91 Å) spuD. However this hydrogen bond is only observed 
between Ser-82 and Asn-62 (the equivalents to Ser-83 and Asn-63 in spuD respectively) in 
spermidine-bound spuE (2.77 Å) while not in apo-spuE (distance 4.52 Å) (Figure I-25a and 
b). Third, in the apo-spuD, the OE2 of Glu-183 establish two strong hydrogen bonds to the 
OG of Ser-180 (2.48 Å) and the OH of Tyr-241 (2.87 Å) (Figure I-25a). These two strong 
hydrogen bonds are also observed in the Ser-180 (2.76 Å) and Tyr-241 (2.63 Å) upon 
putrescine binding (Figure I-25b). In contrast, the OE2 of Glu-181 in the apo-spuE (the 
equivalent to Glu-183 in spuD) fails to establish hydrogen bonding interactions with the Ser-
178 and Tyr-239 (the equivalents to Ser-180 and Tyr-241 in spuD respectively) (Figure I-
25a); however a hydrogen bond is observed between the OE1 of Glu-181 and the ND2 of 
Asn-135 in both apo-spuE and spermidine-bound spuE while the hydrophobic Ile-136 of 
spuD, the equivalent to Asn-135 in spuE, fails to establish hydrogen bond interaction to Glu-
183 in both apo-spuD and putrescine-bound spuD. Fourth, Phe-273 in spuD is replaced by 
Trp-271 in spuE to establish van der Waals to their respective ligand. Fifth, Asn-269, Asp-
180 and Ser-343 are found to hydrogen bond to spermidine either directly or through water 
bridging. In contrast, Gly-271, Thr-182 and Phe-345, their equivalents in spuD, fail to 
establish hydrogen bonding with putrescine.   
    It is noted that three amino acids, Ser-83, Glu-183 and Phe-273 in spuD and their 
corresponding amino acids Ser-82, Glu-181 and Trp-271 in spuE are involved in most of 
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these differences. As these residues are located in the non-overlapping region, we propose 
that they are the determining factor of ligand specificity via interaction at the region occupied 
between the N2 and N3 of spermidine. 
 4.3 Possible ligand binding process in spuD and spuE  
 Based on the identified contrast and common features, the ligand binding in spuD and spuE 
may undergo the following processes. The putrescine first interacts with the Asp-275 in the 
hinge region of spuD, and the strong hydrogen bonding between Asp-275 and Ser-83, 
induces the OH of Ser-83 to shift to a position to coordinate a water molecule with the help 
of Glu-183 (Figure I-25b). Besides establishing a strong hydrogen bond to the N2 of 
putrescine, this water determines the depth of the putrescine binding pocket and blocks the 
way of the ligand to slide deeper. The importance of this water can be addressed by the 
observation that disruption of this water by the mutation of Ser-85 (equivalent to Ser-83 in 
spuD) to alanine or Glu-185 (equivalent to Glu-183 in spuD) to glutamine significantly 
decreases the binding affinity of potF to putrescine and putrescine uptake activities in E.coli 
(Vassylyev et al. 1998). Meanwhile, the hydrogen bond between Tyr-38 and Asp-275 
induces other amino acids from the N domain to move in place. Rotation of the hinge region 
and movement of the N domain induce the amino acids other than Glu-183 from the C 
domain to shift to the proper position. Together, putrescine is locked in place through 
hydrogen bonding and van der Waal interactions with the two domains and the hinge region.   
  On the other hand, the hydrogen bonding interaction between Asp-275 and Ser-83 and 
subsequent recruitment of water through the cooperation with Glu-183 upon ligand binding 
clearly prevents the binding of larger ligand such as spermidine and spermine. The distance 
of water molecule W(4S) in putrescine-bound spuD is 1.4 Å, 1.6 Å and 1.9 Å to the carbon 
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atoms C5, C6 and C7 of the spermidine, respectively; the distance between the OE1 of Glu-
183 in putrescine-bound spuD and the N3 of spermidine is 1.2 Å (shown in Figure I-25b). 
And presence of Gly-271 and Phe-345 in spuD (the equivalents of Asn-269 and Ser-343 in 
spuE) clearly fails to hydrogen bond to spermidine. Moreover, the substitution of Trp-271 in 
spuE by Phe-273 in spuD weakens the van der Waal interactions to spermidine due to the 
lack of one more ring in the side chain of Phe-273. All these differences may explain the 
reason of relatively low binding affinity (Kd = 6.8 μM) of spuD towards spermidine.  
  In the apo spuE, the lack of hydrogen bonding between Asp-273 and Ser-82, and different 
side chain orientation of 181E disrupts the subsequent recruitment of the water molecule in 
the right position that will greatly weaken the binding ability of spuE towards putrescine. 
Moreover, Trp-271 in spuE has a larger hydrophobic side chain than its equivalent Phe-273 
in spuD. Substitution of Phe-273 by Trp in spuD may disfavor the presence of water 
molecule W(4S) in position. This is supported by sequence alignment of spuD, spuE, potF 
and potD (Figure I-24). As shown in the alignment, potF with high binding affinity towards 
putrescine contains Phe-276 (the equivalent of Phe-273 in spuD), while potD with high 
binding affinity towards spermidine has Trp-255 (the equivalent of Trp-271 in spuE). This 
highlights that recruitment of the water to suitable position to hydrogen bond the N2 of 
putrescine in spuD requires the proper conformation of Ser-83 and Glu-183 and presence of 
Phe-273, but not Trp at that position. However the different conformation of Ser-82 and Glu-
181 and presence of Trp-271 in spuE, compared to their equivalents in spuD, act together to 
disfavor the presence of water, which is very important in fastening putrescine in position. 
These differences explain our ITC analysis that spuE has no detectable binding towards 
putrescine. The absence of water molecule in spuE due to the unique conformations of Ser-
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82 and Glu-181 and presence of Trp-271 allows the N2 and N3 part of spermidine to occupy 
the pocket. Moreover, unlike the side chain of Glu-183 in spuD, the side chain of Glu-181 in 
spuE is oriented such that it allows the N2 and N3 part of spermidine to move inside the 
pocket without blockage. Furthermore, Glu-181 strengthens spermidine binding by 
establishing a strong hydrogen bond with the N3 of spermidine (Figure I-25b). The 
importance of Glu-181 of spuE in spermidine binding can be addressed from the previous 
mutation study that E171Q of potD in E. coli (the equivalent to Glu-181 in spuE) 
significantly decreases the binding affinity and uptake activity of potD towards spermidine 
(Kashiwagi et al. 1996). At the same time, the interaction of Tyr-37 from the N domain and 
Asp-273 from the hinge region induces the shift of other amino acids in the N domain to 
establish interactions with the N1 of spermidine. Subsequently, the amino acids other than 
Glu-181 from the C domain shift to hold spermidine tightly inside the pocket. 
4.4 polyamine and T3SS in Pseudomonas aeruginosa  
  T3SS is an important virulence determinant for Gram-negative bacteria pathogens. 
Identification of its key regulators and then design of new antibiotics targeting the key 
regulators may become a promising alternative for the treatment of associated infectious 
diseases. It is clear that spermidine transport system is such a key T3SS regulator, while 
putrescine transport appears to have no role in the regulation of T3SS based on the effects of 
spuD knock-out in our study. However, we cannot rule out the possibility that putrescine 
transport is also involved in the regulation of T3SS. The negative result from our analysis 
might indicate that other unidentified putrescine transport system exists in P. aeruginosa 
PAO1 and hence compensates the potential effect of spuD knock-out. Consistent with this 
view, we notice that several possible polyamine transport genes are in the Pseudomonas 
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genome database v2 (http://www.pseudomonas.com) with gene identification number 
PA1410, PA2711 and PA2592 respectively. Although their function is not confirmed, it 
seems that P. aeruginosa PAO1 owns multiple polyamine transport genes and the gene 
multiplicity underscores the important roles of polyamine involved in the metabolism of P. 
aeruginosa PAO1 and possibly in its virulence.  
    In summary, spuD is found to be a putrescine binding protein and has no effect on the 
T3SS gene expression. In contrast, spuE acts as a spermidine binding protein and shows a 
significant role in the T3SS gene expression. Structural comparison of the apo- and ligand-
bound spuD and spuE provides  novel insight into the mechanism of ligand binding 
specificity, as well as a common mechanism of polyamine binding protein upon ligand 
induced conformational change. We suggest that Ser-83, Glu-183 and Phe-273 in spuD and 
their corresponding amino acids Ser-82, Glu-181 and Trp-271 in spuE play important roles in 
determining their respective ligand binding specificity. These findings deepen our knowledge 
of ligand recognition and polyamine transport in P. aeruginosa and may set a solid 
foundation for later drug design against polyamine transport in P. aeruginosa as polyamines 
have close links with the antibiotics resistances of this strain (Kwon and Lu 2006). However, 
it will be intriguing if spuD and spuE share the common spuFGH for membrane transport. As 
previous studies of polyamine transport in E. coli showed that the major putrescine and 
spermidine ABC systems are distinct (Kashiwagi et al. 1990; Furuchi et al. 1991). Further 





Part II In vitro assembly of decapping activator Lsm1p-7p-Pat1p complex and a 
preliminary structural study of Pat1p carboxyl terminal region 
Summary 
Decapping is a critical and rate-limiting step in the 5’-3’ mRNA decay pathway. It is 
regulated by several decapping activators. One important decapping activator is Lsm1p-7p-
Pat1p, an eight-protein complex. This complex prefers deadenylated mRNAs destined for 
degradation over polyadenylated mRNAs for translation. However, it is not clear how this 
eight-protein complex is assembled and how it interacts with mRNA. In this part, we aim to 
decipher the interaction networks within the complex and study the mRNA binding 
properties of this complex and roles of each individual component in the process of mRNA 
binding. Through Native-PAGE, we identified the interaction networks between Pat1 and the 
Lsm proteins. We found that the carboxyl terminal region (C-region) of Pat1 alone is 
sufficient to interact with the Lsm1-7 heptameric complex and successfully assembled the 
eight-protein complex in vitro. This sets a firm foundation for future structural studies. We 
also tested the mRNA binding properties of the eight-protein complex and each individual or 
subcomplex component in mRNA binding. Our study revealed that Lsm2 and Lsm3 are 
important not only for facilitating binding between the Pat1 C-region and Lsm1-7 protein 
complex but also for Lsm1-7-Pat1-mediated mRNA binding. These findings have not been 
reported previously. In addition, we crystallized and performed a preliminary structural study 





Chapter 1 Introduction 
1.1 Post transcriptional regulation  
Post transcriptional regulation of gene expression is a key aspect in eukaryotes. Regulation 
includes several key steps: mRNA processing (5’ capping, splicing and 3’ poly (A) tail 
formation), transport, surveillance, translation and degradation (Figure II -1). Regulation on 
these key steps effects the control of quality and quantity of mRNA, which consists of a pool 
of non-translated and translated transcripts. mRNA decay and mRNA translation are often in 
a competitive relationship (Jacobson and Peltz 1996; Coller and Parker 2004). mRNA decay 
is coupled with translation repression, while mRNA translation is coupled with the repression 
of mRNA decay.  
 




Figure II -1.  Post transcriptional regulation points of eukaryotic mRNA. Pre-mRNA is 
transcribed from DNA by RNA polymerase II (RNAP II). Pre-mRNA is processed to mature 
mRNA by 5’-end capping, 3’-end cleavage, polyadenylation and splicing. After processing, 
mature mRNAs are assembled into messenger ribonucleoprotein particles (mRNPs) and then 
exported from the nucleus to the cytoplasm via the nuclear pore complex (NPC). In the 
cytoplasm, mRNA undergoes a quality check for any aberrant transcripts. Non-sense 
mediated mRNA decay (NMD) is activated when a pre-stop codon is harbored within a 
transcript. After the quality check, the mRNA is translated into protein or degraded based on 
the dynamic balance between translational pool and degradative pool. Figure is modified 
from the reference Aguilera 2005.   
  
1.1.1 5’-end processing 
The nascent mRNA with a length of 22-25 nucleotides is capped with a 7-methyl guanosine 
at its 5’-end by cap enzymes (Moteki and Price 2002). Cap enzymes in yeast include Cet1-
Ceg1 with triphosphatase and guanylyltransferase activities, and Abd1 with guanine-N7-
methyltransferase activity (Aguilera 2005). Capped nascent pre-mRNA is recognized by the 
nuclear cap binding protein complex (CBC). The interaction between the cap structure and 
CBC complex is important for subsequent pre-mRNA processing (Das et al. 2003).  
1.1.2 3’-end processing 
After transcription, most pre-mRNAs in eukaryotes have to be modified at the 3’-end by 
cleavage and polyadenylation. 3’-end processing requires both cis-elements in the pre-
mRNAs and trans-factors. Cis-elements in mammals include three primary sequence 
fragments that determine the polyadenylation and cleavage site. The three cis-elements are 
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the conserved AAUAAA polyadenylation signal (PAS), the cleavage site and the less 
conserved downstream elements (DSE). These cis-elements are recognized by the cleavage 
and polyadenylation specificity factors (CPSF) and poly(A) polymerase (PAP). After correct 
positioning of the cis-elements by these trans-factors, the poly(A) tail will be synthesized to 
around 200-300 bases in length. Polyadenylation at the 3’-end have important roles in the 
regulation of transcription, splicing, translation and mRNA stability (Mandel et al. 2008).  
1.1.3 Splicing 
A characteristic feature in eukaryotes is that most genes contain introns. There are several 
advantages of harboring introns inside genes. Firstly, transcription of one pre-mRNA via 
alternative splicing may generate more mRNA transcripts and hence provide more specific 
and subtle functions within different cell types. Secondly, mutations inside introns do not 
alter the final mRNA transcript, thus maintaining the stability and function of the synthesized 
protein. Splicing of pre-mRNAs is carried out in the spliceosome, which is conserved from 
yeast to human (Mandel et al. 2008). Spliceosome is a highly dynamic and protein-rich 
machine with around 170 proteins (Wahl et al. 2009). The spliceosome comprises five small 
ribonucleoprotein particles (snRNPs), U1, U2, U4, U5 and U6. Seven Sm proteins (B, D1, 
D2, D3, E, F and G) are found to be involved in the biogenesis of U1, U2, U4 and U5 
snRNPs through the interaction with a conserved sequence present in these snRNPs (Branlant 
et al. 1982). These snRNPs are assembled into a series of stepwise discrete complexes. The 
early (E) complex is initiated by the interaction of the U1 snRNP with the 5’ splice site. 
Following the E complex formation, the A complex (or pre-spliceosome) is formed by the 
association of the U2 snRNA–branch-region duplex. After recruitment of the B complex 
(U4-U5-U6 snRNPs) to the A complex, this bigger complex is rearranged to yield the mature 
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spliceosome C complex (U1-U2-U4-U5-U6). The C complex functions in splice site 
recognition, intron excision and exon ligation. Concomitant with splicing, the exon junction 
complex (EJC) is recruited to the newly processed mRNAs at the region 24-nucelotide 
upstream of the exon junction sites. The EJC functions in a series of cellular processes, 
including mRNA export from the nucleus to the cytoplasm, subcellular localization, 
translation and quality control (Tange et al. 2004; Giorgi and Moore 2007).  
1.1.4 Export 
After processing, the pre-mRNAs turn into mature mRNAs. The mature mRNAs are 
assembled into mRNPs and associated with the transcription export complex (TREX). TREX 
is composed of the THO complex and several export factors such as Sub2, Yra1, ALY. 
Through ALY of TREX, two major export receptors, the heterodimer Nxf1-Nxt1 is recruited 
to the mRNPs. Via the Nxf1-Nxt1 pathway,  mRNPs are docked to NPC and then transported 
across the nucleus and released into the cytoplasm (Carmody and Wente 2009). 
1.1.5 Translation 
Following export into the cytoplasm, mRNAs are recruited into the ribosomes for protein 
synthesis. The ribosomes are highly conserved across all species from prokaryotes to 
eukaryotes. The ribosomes (70S in bacteria and 80S in eukaryotes) are composed of two 
subunits: the small subunit (30S in bacteria and 40S in eukaryotes) and the large subunit (50S 
in bacteria and 60S in eukaryotes). The small subunit functions in the correct base pairing of 
the triplet codons in the mRNA with the anticodons of the corresponding tRNAs, and 
decodes the genomic information into the peptide sequence information. The large subunit 
contains the peptidyl-transferase center and functions in peptide bond formation. Three tRNA 
binding sites have been identified and they cooperate closely for peptide synthesis. These 
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three tRNA binding sites are the aminoacyl-tRNA binding site (A site), peptidyl-tRNA 
binding site (P site), and deacylated tRNA binding site (E site) (Steitz 2008). 
Translation contains four stages: initiation, elongation, termination and ribosome recycling. 
In eukaryotes, the 40S small subunit with Met-tRNA and initiation factors eIFs 1, 1A, 2, 3 
and 5 is recruited to the 5’ capped mRNA via the cap binding complex eIF4F (composed of 
eIF4A, eIF4E and eIF4G). Then the 40S subunit with these initiation factors scans along the 
mRNA until a start codon AUG is encountered. Through base pairing, the anticodon Met-
tRNA within the 40S subunit is anchored to the start codon and then triggers the recruitment 
of the large subunit 60S to assemble into a whole ribosome 80S for translation initiation and 
elongation. Translation terminates when a stop codon in the A site is encountered. Eukaryotic 
class I release factor 1 (eRF1) in conjunction with class II release factor eRF3 hydrolyze the 
ester-linked peptide in the peptidyl-tRNA of the P site and the newly synthesized peptide is 
released from ribosome. After peptide release, the whole ribosome is disassembled into the 
two distinct subunits for a subsequent round of translation (Steitz 2008; Sonenberg and 
Hinnebusch 2009). Translation control is very important in maintaining cellular homeostasis 
and it mainly occur at the initiation stage (Sonenberg and Hinnebusch 2009).  
1.2 mRNA decay 
After the functions of mRNAs are fulfilled, they enter the degradation pathway. mRNA 
decay is an important post-transcriptional checkpoint in the aspect of quantitative and 
qualitative control of transcripts. The importance of quantitative control of mRNAs is to 
maintain a dynamic balance between the pools of non-translated and translated transcripts. In 
contrast, aberrant mRNAs, generated during the process of mRNA synthesis either from 
transient mistakes or from inherited genetic mutations, may interfere with the functions of 
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normal transcripts and cause any associated disorders. Hence, efficient elimination of these 
aberrant transcripts requires quality surveillance systems. 
1.2.1 Normal mRNA decay 
In eukaryotes, two major pathways of normal mRNA decay have been identified (Parker and 
Song 2004), namely the 5’-3’ pathway and the 3’-5’ pathway (Figure II -2). Both pathways 
are initiated by a common step, poly(A) tail shortening (deadenylation) by a Ccr4/Pop2/Not 
deadenylase complex (Meyer et al. 2004; Parker and Song 2004). In the 5’-3’ pathway, after 
deadenylation, the transcripts are subject to decapping by the decapping enzyme 
(Dcp1/Dcp2), and then further degraded by the 5’-3’ exonuclease Xrn1 (Decker and Parker 
1993). Alternatively, in the 3’-5’ pathway, following deadenylation, the transcripts are 
degraded by the exosome, a cytoplasmic protein complex with 3’-5’ exonuclease activity 
(Anderson and Parker 1998). The remaining oligonucleotide cap structure after exosome 























Figure II -2. Normal mRNA decay pathways in eukaryotes. Figure is modified from the 
reference Coller and Parker 2004.  
  mRNA decay can occur in cytoplasmic loci referred to as processing bodies (P bodies or 
DCP bodies or GW bodies), which are conserved in eukaryotes (Sheth and Parker 2003). P 
bodies are visible granules when viewed under a light microscope and dynamic sites for non-
translational mRNA transcripts either for decay or for storage (Parker and Sheth 2007). 
Although the exact components of P bodies are not clear, components identified to date can 
be roughly categorized into three classes (Parker and Sheth 2007). First, a large multi-subunit 
core of proteins forms the general translation repression/decay machinery. This core is 
conserved from yeast to mammals. The core is composed of the decapping hetero-enzyme 
Dcp1/Dcp2, the decapping activators Pat1p, Lsm1p-7p complex, Dhh1p, Edc1p, Edc2p and 
Edc3p, the 5’-3’ exonuclease Xrn1p, and the deadenylase complex CCR4/POP2/NOT 
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(Shown in Figure II -3) (Parker and Sheth 2007). Second, mRNAs under translation 
repression or decay are found in P bodies (Teixeira et al. 2005). P bodies disrupt when 
treated with RNase A (Teixeira et al. 2005). This is strong evidence to show that the 
assembly of P bodies requires the existence of RNAs and it suggests that the size and number 
of P bodies may be associated with the quantity of non-translated mRNAs within P bodies. 
Consistent with this view, the number and size of P bodies increase when a non-translating 
mRNA fragment is overexpressed in yeast (Teixeira et al. 2005). Third, some specific 
components restricted to particular organisms or mRNAs are found in P bodies. For example, 
the nonsense-mediated mRNA decay factors Upf1p, Upf2p and Upf3p have been found in P 
bodies of certain Saccharomyces cerevisiae mutants (Sheth and Parker 2006). On the other 
hand, some proteins that are involved in microRNA silencing have been detected in 
metazoan P bodies, but not in Saccharomyces cerevisiae P bodies (Jakymiw et al. 2005; Liu 
et al. 2005).  
 
Figure II -3.  The core components of mRNA decay and translation repression 
machinery in P body. Figure is modified from the reference Coller and Parker 2004. 
 
1.2.2 mRNA surveillance pathways 
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Abnormal mRNAs may occur during the process of mRNA synthesis. These aberrant 
transcripts could compromise the functions of normal transcripts. Three types of mRNA 
surveillance systems have been identified to minimize these abnormalities, including the 
nonsense-mediated mRNA decay (NMD), non-stop mRNA decay (NSD), and no-go mRNA 
decay (NGD) (Clement and Lykke-Andersen 2006; Isken and Maquat 2007) (Figure II -4). 
NMD 
  NMD is a translation-dependent surveillance system that detects mRNAs containing a 
premature translation termination codon (PTC) and triggers elimination of such aberrant 
transcripts. Synthesis of C-terminal truncated proteins may exert a dominant-negative effect 
by competing with the functions of  respective full length proteins (Holbrook et al. 2004). It 
has been observed that around one third of the known human diseases associated with 
mutations result from the production of non-sense mRNAs (Holbrook et al. 2004). This 
observation stresses the pathological role of these aberrant transcripts. Therefore, 
understanding the mechanism of NMD may bring in a promising therapeutic strategy to deal 
with these diseases (Welch et al. 2007). 
  In the NMD, the key issue for cells to make a decision is how to distinguish normal 
translation termination codon from pre-mature stop codon. In mammal cells, two NMD 
models have been proposed, namely, an EJC-dependent premature termination and a faux 3’-
untranslated region (UTR) mediated premature termination (Wen and Brogna 2008). 
Normally, an EJC is located within 20-24 nucleotides upstream of the exon-exon boundary. 
During the process of translation, the EJC is replaced by ribosome translation machinery. 
However, when a stop codon located 50-55 nucleotides upstream of the last exon-exon 
boundary is encountered, this stop codon is defined as a PTC and translation machinery fails 
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to displace the EJC. Subsequently, NMD is triggered through the recruitment of NMD 
factors to the EJC (Maquat 2004). Recently, several observations challenge this EJC-
dependent premature termination model. For example, NMD could occur even in the absence 
of 3’ most intron and the efficiency of NMD is affected by the length of 3’ UTR (Buhler et 
al. 2006). Another example is that a NMD sensitive β-globin mRNA shows resistance to the 
NMD by artificially modifying the relative position between the poly(A) binding protein 
(PABP) and a downstream PTC (Silva et al. 2008). These observations indicate an alternative 
NMD model in mammals, namely the faux 3’-untranslated region (UTR) mediated premature 
termination, which has been observed in S. cerevisiae (Amrani et al. 2004).  
  Exact NMD trans-factors vary among species, however, three core factors, up-frame shift 1 
(Upf1), Upf2 and Upf3, are highly conserved across species and form a surveillance complex 
with the Upf2 sandwiched by the Upf1 and Upf3. This complex can physically interact with 
the ribosome and EJC through Upf1 and Upf3 respectively (Wen and Brogna 2008). 
Moreover, this complex has been found to interact directly or co-immnopurifiy with the 
general mRNA decay components such as DCP2, Xrn1, exosome, and deadenylase PARN 
(He and Jacobson 1995; Lykke-Andersen 2002; Lejeune et al. 2003).  These interactions with 
the general mRNA decay machinery could direct non-sense mRNAs to decay either in a 
deadenylation-independent manner or through deadenylation and 3’-5’ decay pathway 
(Mitchell and Tollervey 2000; Lejeune and Maquat 2005). In contrast to the mRNA decay 
from the both ends, the decay of non-sense mRNAs in Drosophila occurs through an 
endonucleolytic cleavage near the PTC region, followed by exonucleolytically rapid 
degradation from both directions (Gatfield and Izaurralde 2004).  
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Figure II -4. mRNA surveillance pathways. a)  The mRNA with a premature stop codon is 
recognized by NMD factors and degraded throught the exonucleolytic pathways from both 
ends.  b) The mRNA without stop codon is degraded by the exosome from the 3’ end.  c)  
The mRNA with a stem-loop secondary structure hinders translation elongation. This 
hindrance is recognized by the no-go decay factors Dom34/Hbs1 and cleaved by an 
unidentified endonucleose. This figure is adapted from Clement and Lykke-Andersen 2006. 
NSD 
Non-stop mRNAs have been studied in S. cerevisiae and human. Non-stop mRNAs cause 
ribosome stalled at the 3’ end and leave an empty A site in the ribosome. This stall may 
trigger the NSD through the recruitment of exosome-associated Ski7 factor to the A site and 
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thus degrade the aberrant transcripts by the exosome in 3’-5’ direction (van Hoof et al. 2002). 
This process is independent of deadenylation as the lack of stop codon may disrupt a normal 
environment of 3’ UTR and interfere with the formation of poly(A) tail. Alternatively, NSD 
can be initiated in 5’-3’ pathway when Ski7 is absent (Isken and Maquat 2007). The 
physiological significance of NSD may include two aspects: to eliminate the dead-end 
transcripts and to release the stalled ribosome for synthesis of other mRNAs (Isken and 
Maquat 2007).  
NGD  
NGD has only been studied in S. cerevisiae. It was identified through an artificial insertion of 
stem-loop structure into mRNAs, resulting in the blockage of translation elongation (Doma 
and Parker 2006). This blockage triggers NGD through endonucleolytic cleavage of mRNAs 
near the position where translation elongation hinders. The resulting free ends of mRNAs are 
further degraded by the exosome and Xrn1 from the directions of 3’ and 5’ respectively. Two 
proteins, Dom34 and Hbs1, are found to play an important role in NGD. Dom34 is a 
paralogue of eRF1, which structurally resembles a tRNA molecule while Hbs1 is related to 
eRF3 and belongs to the translational GTPase subfamily. It is thought that Dom34 can 
recognize the stalled ribosome and thus trigger the endonucleolytic cleavage of the no-go 
mRNAs. However the identity of the endonuclease is still not known.  
    In summary, the three mRNA surveillance systems are all closely associated with the 
translation processes. When translation stalls abnormally either at the elongation or the 
termination stage, mRNA surveillance systems will be activated to eliminate these aberrant 
transcripts through the recruitment of the general mRNA decay machinery. 
1.2.3 Decapping regulation 
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Decapping is a rate-limiting step in 5’-3’ mRNA decay. Two broad decapping regulators 
(decapping activators and decapping inhibitors) have been identified. Decapping inhibitors 
comprise the poly (A) tail binding protein (Pab1p) (Caponigro and Parker 1995) and cap 
binding protein eIF-4E (Schwartz and Parker 1999; 2000). The mechanism of decapping 
inhibition by Pab1p might be through two possible ways. First, Pab1p interacts directly with 
eIF-4G, a component of the cap binding complex eIF-4F (Tarun and Sachs 1996). eIF-4F can 
recruit the 40S ribosome subunit to the mRNA through the interaction of its subunit eIF-4G 
with eIF3, a ribosome bound initiator factor. Studies show that the cap binding complex can 
inhibit decapping (Schwartz and Parker 1999; 2000). Therefore, the inhibition of decapping 
by Pab1p can be through its interaction with the cap binding complex eIF-4F. Second, Pab1p 
interacts with the cap structure directly in vitro and therefore may block the decapping 
activity of Dcp1/Dcp2 by this interaction (Khanna and Kiledjian 2004).  Decapping 
activators contain Pat1p, Lsm1p-7p, Dhh1, and Edc1-3 proteins (Schwartz et al. 2003; Coller 
and Parker 2005).  
  Dhh1 is a DEAD-box RNA helicase that is conserved across species. It is required for 
translation repression and stimulation of decapping in vivo (Coller and Parker 2005).  Edc1 
and Edc2 are basic proteins with low sequence identity with each other. They were found to 
enhance the efficiency of decapping in vitro by direct binding to the mRNA substrate (Coller 
and Parker 2004). Edc3 contains a Sm-like domain at the N-terminus, a central FDF domain 
and a C-terminal YjeF-N domain. It enhances decapping and P-body formation, possibly 
through the dimerization of YjeF-N domain (Ling et al. 2008). Besides being a general 
mRNA decay factor, Edc3 can also modulate the specific Rps28B mRNA decapping (Coller 
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and Parker 2004). Details of Pat1p and Lsm1p-7p in decapping activation are reviewed 
below. 
1.2.4 Pat1 in decapping, P-body formation and translation repression 
Pat1 is an important protein functioning in the processes of mRNA decapping, P body 
formation and translation repression (Pilkington and Parker 2008). Pat1 is conserved in 
Saccharomyces cerevisiae, Drosophila melanogaster, and mammalian cells (Eulalio et al. 
2007; Scheller et al. 2007). The interaction partners of Pat1 in Saccharomyces cerevisiae 
include Dcp1, Dcp2, Lsm1-7, Dhh1 and Xrn1 (Coller and Parker 2004). Deletion of Pat1p in 
yeast shows a significant reduction in translation repression under glucose deprivation 
(Coller and Parker 2005) and a significant defect in decapping (Tharun et al. 2000). 
Overexpression of Pat1 in Saccharomyces cerevisiae enhances P-body assembly (Coller and 
Parker 2005). In Saccharomyces cerevisiae, Pat1 is a 796-amino acid protein (Figure II -5). 
Distinct functional domains in Pat1 have been identified based on deletion studies 
(Pilkington and Parker 2008). The region of amino acids 254-422 determines the decapping 
activity of Pat1 and deletion of this region has a similar effect to that of deletion of full length 
Pat1 on decapping efficiency. The region of amino acids 422-763 is involved in promoting 
Pat1’s accumulation in P bodies, translational repression, and association with Lsm1 and 
recruitment of Lsm1 to P bodies. Furthermore, this region is responsible for cell growth 
inhibition when overexpressed. In addition, Pat1 is an RNA-binding protein, in which the 
regions of amino acids 254-422 and 422-763 interact independently with poly (U).  
Moreover, the poly (U) binding property seems to be specific as the interaction can not be 





Figure II -5. Pat1 from Saccharomyces cerevisiae contains several conserved regions. 
Figure is modified from the reference Pilkington and Parker 2008.  
 
1.2.5 Lsm proteins in pre-mRNA processing and mRNA decay 
Lsm proteins (Sm like proteins with molecular weights between 8-28 kDa) are a conserved 
family of proteins characterized by a “Sm motif” identified in Sm proteins (Hermann et al. 
1995; Seraphin 1995). The Sm motif is composed of an amino-terminal α helix, followed by 
five anti-parallel β strands (Kambach et al. 1999). This motif forms two domains, namely the 
Sm domain I and Sm domain II. The Sm domain I contains α helix and a β sheet (β1-3) while 
the Sm domain II comprises β strands β4-5. The two domains are generally connected by a 
long loop region. Eight Lsm proteins (Lsm1-8) are conserved in eukaryotes, and two distinct 
heptameric complexes, known as Lsm1-7 and Lsm 2-8, are formed (Salgado-Garrido et al. 
1999; Bouveret et al. 2000; Tharun et al. 2000). Lsm1-7 complex is localized in the 
cytoplasm and functions as mRNA decapping activator (Salgado-Garrido et al. 1999; 
Bouveret et al. 2000) but is not involved in splicing (Bouveret et al. 2000). In contrast, Lsm2-
8 is localized in the nucleus, binds to U6 snRNA, forms the core of U6 related snRNP, and 
functions in pre-mRNA splicing (Salgado-Garrido et al. 1999). Meanwhile, Lsm2-8 is also 
involved in the degradation of pre-mRNAs and mRNAs restricted in the nucleus (Kufel et al. 
2004), although it is not involved in mRNA decay in the cytoplasm (Tharun et al. 2000). 
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  Lsm1-7 is found to physically interact with several mRNA decay factors from the 5’-3’ 
decay pathway based on two-hybrid interaction and coimmunoprecipitation studies. These 
factors include Pat1, Dhh1, the decapping enzyme Dcp1, Dcp2, the 5’-3’ exonuclease Xrn1, 
and Upf1 as well as mRNA (Fromont-Racine et al. 1997; Bouveret et al. 2000; Tharun et al. 
2000; Coller and Parker 2004).  
  Chowdhury et al. (2007) found that Lsm1-7-Pat1 complex can bind to mRNA near its 3’-
end, and the presence of a stretch of U residues near the 3’-end of mRNA enhances this 
complex binding. More importantly, this complex interacts strongly with oligoadenylated 
mRNAs when compared with polyadenylated mRNAs. This property distinguishes 
oligoadenylated mRNA destined for degradation from polyadenylated mRNA destined for 
translation. This may be the basis of the in vivo function of the complex as a decapping 
activator and translation repressor. However, when synthetic homo-oligoribonucleotides (20-
mers) were used to test the RNA binding of this complex, only oligo(U) was observed to 
have a detectable binding with this complex. On one hand, this finding supports the general 
binding preference of Sm-like protein complexes for U-rich sequences (Achsel et al. 1999; 
Achsel et al. 2001; Toro et al. 2001; Schumacher et al. 2002), and, on the other, failure of 
interaction with oligo(A) indicates that the stronger interaction with oligoadenylated mRNAs 
over that with polyadenylated mRNAs not only depends on the presence of oligo(A) tail but 
also other adjacent sequences such as a stretch of U residues or yet unidentified sequences. In 
addition to the well-known role of Lsm1-7-Pat1 complex as an activator in mRNA decay, 
Lsm1-7 proteins also play a role in the stabilization of certain mRNAs. It has been known for 
about 20 years that the 5’-end of many orthopoxvirus mRNAs contains a unique 
nontemplated poly(A) tract of 5 to 40 residues, although the function of this poly(A) tract is 
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not clear (Patel and Pickup 1987; Schwer et al. 1987; Ahn and Moss 1989; Ink and Pickup 
1990). Recently, Bergman et al. (2007) found that the presence of this 5’ poly(A) tract is able 
to stabilize mRNAs by repressing mRNA decay in both pathways, i.e. 5’-3’ and 3’-5’. 
Moreover, Lsm1-7 complex is identified to be a trans-factor that specifically associates with 
and stabilizes the mRNAs containing a 5’ poly(A) tract of 10 to 21 in length. It is proposed 
that Lsm complex may bind to the 5’ and 3’ ends of such mRNAs simultaneously and 
therefore inhibit mRNA decays from the both ends. However, it seems that binding of 5’ 
poly(A) tract by the Lsm1-7 complex is not direct as addition of excess poly(A) failed to 
inhibit this binding. This observation is similar to that made by Chowdhury et al. (2007), 
which underscores that binding of either 3’ oligo(A) tail or 5’ poly(A) tract by Lsm1-7 
complex requires other sequences yet unidentified.    
  Recently, the crystal structure of Lsm3 from Saccharomyces cerevisiae was reported 
(Naidoo et al. 2008). Lsm3 forms an octamer ring structure with an α-helix face at one end 
and a loop face at the other end (Figure II -6a, 6b and 6c).  Each monomer is characterized 
by the typical “Sm motif” with an α helix at the N terminal, followed by five anti-paralleled β 
strands (Figure II -6d). Based on the available interaction networks and structure of Lsm3, 
an updated model for the organization of Lsm1-7 and Lsm2-8 heptameric ring is shown in 





Figure II -6. Crystal structure of Lsm3 and models for Lsm1-7 and Lsm2-8. Helix is 
shown in blue; loop region between β3 and β4 is shown in magenta; other regions are shown 
in green. a) Lsm octameric ring viewed from the helix face. b) Lsm octameric ring viewed 
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from the loop face. c) A side view of Lsm octameric ring. d) Structure of Lsm3 monomer. e) 
Model for Lsm1-7 viewed from the helix face, colored by electrostatic potential distribution 
(red for negative charge and less than -0.5 kT/e, blue for positive charge and more than 0.5 
kT/e. f) Model for Lsm2-8. Orientation and color are identical to Lsm1-7. Figure a-d was 
generated from PDB code 3BW1 and e-f was adapted from the reference Naidoo et al., 2008. 
1.3 Rationale and aims 
Structural study of Lsm1-7-Pat1 may provide important insight into the mechanisms of 
mRNA recognition and decapping activation by this complex. The primary challenge in the 
structural study of this eight-protein complex is that sufficient quantity and purity of the 
complex have to be achieved. Currently, there is no protocol of successful assembly of the 
complex with sufficient quantity and purity suitable for structural study, although through a 
tandem affinity strategy, the Lsm1-7-Pat1 complex and Lsm1-7-Pat1-Xrn1 complexes have 
been purified from Saccharomyces cerevisiae (Bouveret et al. 2000; Chowdhury et al. 2007). 
However, in both studies, Pat1 shows several bands indicating protein degradation during the 
process of purification. Moreover, yields of the recovered complexes are low due to the 
intrinsic expression under the native promoter. The low yields make the structural study of 
this complex difficult. Evidence has shown that the C-region of Pat1 may be the region that 
interacts with Lsm1-7 complex (Pilkington and Parker 2008). Although it is clear that Lsm1-
7 and Pat1 can form an eight-protein complex, the subunits in the Lsm1-7 complex that are 
responsible for Pat1 interaction are not known. Also the role that each protein plays in the 
process of RNA binding is unclear though it has been established that Lsm1-7-Pat1 complex 
can bind mRNA near the 3’ end containing a U-rich region (Chowdhury et al. 2007). 
The aims of this study were to: 
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• reassemble the Lsm1-7-Pat1 complex of good quality and sufficient quantity in vitro.  
• delineate the interaction networks within the Lsm1-7-Pat1 eight-protein complex 
• explore the individual roles of the Lsm1-7-Pat1 complex in RNA binding 
• solve the structure of Pat1 C-region by X-ray crystallography.  
Chapter 2 Methods 
Most methods and materials for protein purification and crystallization are similar to the 
methods described in Part I unless otherwise stated. 
 
2.1 Gene cloning, protein expression 
 















Primer lists for Saccharomyces cerevisiae Lsm (short for Lsm hereafter) (Done by Dr. 
Shimin Jiang in our lab and restriction site is underlined) 
 
Lsm1-BamHI-F: CGGGATCCATGTCTGCAAATAGCAAG  
 
Lsm1-XhoI-R:   CCGCTCGAGTTAGTACATGTCAGATTT  
 
Lsm4-BamHI-F:  CGGGATCCATGCTACCTTTATATCTT  
 
Lsm4-XhoI-aa117-R: CCGCTCGAGTTAAAATTCGACCTTTTG  
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Lsm2-BamHI-F: CGGGATCCGATGCTTTTCTTCTCC  
 


















Lsm7-HindIII-R: CCCAAGCTTCTATTTTTGCATATATAG  
                            
Cloning vector lists 
 
 
pGex-6p-1 Pat1 constructs, Lsm1, Lsm4  
pETDuet-1 Lsm2, 3, 5, 6  




BL 21 (DE3) RIL for all Pat1 constructs. 
 
BL 21 (DE3) for all Lsm constructs. 
 
SDS-PAGE 
As the molecular weights of Lsm2, 3, 4, 5, 6 and 7 are similar, in order to achieve good 
visualization on an SDS-PAGE gel, we used a commercial NuPAGE 4-12% Bis-Tris gel 
(Invitrogen) according to the manufacturer’s instructions.  
2.2 Protein purification 
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Buffer lists for all constructs using pGex-6p-1 as the cloning vector including Pat1 




Cell Lysis Buffer  
20 mM Tris-HCl, pH 8.0, 500 mM NaCl,   
2mM dithiothreitol (DTT), Roche EDTA free 
protease inhibitor tablet 
Elution Buffer 20 mM Tris-HCl, pH 8.0, 500 mM 
NaCl,2mM dithiothreitol (DTT), 20 mM 
reduced  Glutathione 
Desalting Buffer 20 mM Tris-HCl, pH 8.0, 100 mM 
NaCl,2mM dithiothreitol (DTT) 
Gel Filtration Buffer 20 mM Tris-HCl, pH 8.0, 100 mM 
NaCl,2mM dithiothreitol (DTT) 
 
Buffer lists for all constructs using Duet-1 as the cloning vector including Lsm2-3 and 
Lsm5-6-7. 
 
Cell Lysis Buffer  10 mM HEPES, pH 7.6, 200 mM NaCl, 
Roche EDTA free protease inhibitor tablet 
 
Wash Buffer  10 mM HEPES, pH 7.6, 200 mM NaCl, 5mM 
imidazole  
Elution Buffer  10 mM HEPES, pH 7.6, 200 mM NaCl, 
250mM imidazole 
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Gel Filtration Buffer 10 mM HEPES, pH 7.6, 100 mM NaCl, 2mM  
dithiothreitol (DTT) 
 
  Briefly, GST-fused proteins were purified following cell lysis, first GST affinity column 
chromatography, elution by reduced glutathione, overnight cleavage by PreScission protease, 
desalting, and second GST affinity column chromatography to remove the cleaved GST tags 
and any uncleaved GST-fusion proteins. Target proteins were further purified by gel 
filtration chromatography using appropriate buffers as listed above. Both Pat1-465c and 
Pat1-473c were concentrated to 10 mg/ml. The final concentrations of Lsm1 and Lsm4 were 
4 mg/ml. SeMet-incorporated Pat1-465c and Pat1-473c constructs were expressed in a 
minimal medium containing 20 mg/l seleno-L-methionine (SeMet), and purified in the same 
way as that of native Pat1 proteins except 10 mM DTT was included at every step of 
purification.  
  Duet-1 expressed proteins were purified using TALON Resin (CLONTECH). Cells were 
sonicated and cell pellets were removed through centrifugation. Supernatants were mixed 
with TALON Resin for 1 hour at 4°C. The resins were harvested and washed extensively 
using wash buffer. Final target proteins were eluted with elution buffer and further purified 
by gel filtration chromatography. Final concentrations of protein were 20 mg/ml for Lsm2-3 
and 15 mg/ml for Lsm5-6-7.   
2.3 Native-PAGE 
Gel preparation and running was similar to SDS-PAGE except SDS was not included in the 
gel and running buffer. Samples of different combinations at equal molar ratio were 
incubated at room temperature for 30 min before running in the gels except the preparation of 
Lsm1-7-Pat1-465c complex, in which Lsm1, Lsm4, Lsm2-3 and Lsm5-6-7 were incubated 
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together for 15 min before addition of Pat1-465c for another incubation of 15 min.The gels 
were run at room temperature at constant current 12 mA. The percentage of stacking gel and 
running gel was 5% and 8% respectively. The amount of protein loaded into the lanes of each 
gel was comparable. 
2.4 Reconstitution of Lsm2-3-Pat1-465c, Lsm1-7 and Lsm1-7-Pat1-465c 
As for the reconstitution of trimeric Lsm2-3-Pat1-465c, equimolar amounts of Lsm2-3 and 
Pat1-465c were mixed and incubated at room temperature for 20 minutes. As for the 
reconstitution of Lsm1-7 and Lsm1-7-Pat1-465c, individual protein (Lsm1, Lsm4, and Pat1-
465c) or subcomplexes (Lsm2-3 and Lsm5-6-7) were mixed in equal molar in 8M urea for 20 
minutes at room temperature. High urea concentration was supposed to disrupt any potential 
ring formation ability of Lsm2-3 and Lsm5-6-7 and enhance the assembly of Lsm1-7. After 
incubation, these mixtures were loaded into gel filtration column S200 26/60 (Amersham) for 
purification which was preequilibrated in the same buffer as that for purification of Lsm2-3 
and Lsm5-6-7.  
2.5 Crystallization 
Crystal screening was carried out using a Phoenix liquid handling robot (Rigaku). Initial 
crystallization hits were optimized using the hanging drop vapor diffusion method and 
seeding in combination with additive screening (Hampton).  
All crystals grew under 1 ml of reservoir solution. For the semet-Pat1-465c, 1 µl of protein 
sample was mixed with 1 µl of 0.1 M Tris HCl, 10 mM DTT, 10% MPD, 20% polyethylene 
glycol (PEG) 3350, pH 7.4. For the semet-Pat1-473c, 1 µl of protein sample was mixed with 
1 µl of 0.085 M Hepes Na, 16% PEG 3350, 15% glycerol, 6% MPD, pH 7.5. For the Lsm2-
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3-Pat1-465c, 1 µl of protein sample was mixed with 1 µl of 0.05 M Hepes Na, 6% PEG 
3350, pH 7.0.  
2.6 Data collection 
Se absorption edge data of Pat1-465c and Pat1-473c were collected at beamline ID23-1 
(European Synchrotron Radiation Facility). As crystals decayed quickly after Se absorption 
edge data set, inflection and remote data set were not processed.  
2.7 Surface Plasmon Resonance (SPR) 
SPR was carried out on a Biacore 2000 instrument (Biacore). The 5’ end biotin labeled 
ssRNAs 15mer polyU purchased from DHARMACON was attached to a streptavidin-coated 
sensor chip (Biacore). A buffer of 10 mM HEPES, pH7.6, 100 mM NaCl, 2mM Mgcl2 was 
flowed across the chip until the baseline was stable. The 5’ end biotin-labeled polyU was 
then attached to flow cell 2 by injecting 20 μl of 100nM RNA in 0.3 M NaCl at a flow rate of 
5 μl/min. After immobilization, flow cell 2 and reference flow cell 1 were blocked with 100 
μl of 1 mg/ml biotin at 5 μl/min. A binding buffer of 10 mM HEPES, pH7.6, 100 mM NaCl, 
2 mM MgCl2, 2 mM DTT was flowed across flow cells 1 and 2. Proteins were dialyzed into 
the binding buffer prior to injection. 60 μl of protein with a serial concentration gradient of 
50-1000 nM was injected across the chip at 30 μl/min. Dissocation was followed with 3-
minute interval. Regeneration was done after each cycle of association and dissociation by 
injection of 30 μl 1M NaCl at 30 μl/min. The data were fitted to a 1:1 binding mode with 
mass transfer using BIAevaluation 3.1. 
Chapter 3 Results and Discussion 
3.1 Protein purification  
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After the first and second GST affinity column chromatography, Pat1-465c, Pat1-473c, 
Lsm1, and Lsm4 were further purified using gel filtration chromatography. The gel filtration 
profiles and protein purity checked with NuPAGE are shown in Figure II -7, Figure II -8, 




Figure II -7. Purification of semet-Pat1-465c. a) Elution profile of gel filtration 




Figure II -8. Purification of semet-Pat1-473c. a) Elution profile of gel filtration 
chromatography from S200 26/60. b) Peak fraction at 232.9 ml was checked by NuPAGE. 
 
 
Figure II -9. Purification of Lsm1. a) Elution profile of gel filtration chromatography from 




Figure II -10. Purification of Lsm4. a) Elution profile of gel filtration chromatography 
from S200 26/60. b) Peak fraction at 244.5 ml was checked by NuPAGE. 
  Duet-1 expressed proteins of Lsm2-3 and Lsm5-6-7 were purified using TALON Resin 
affinity chromatography and followed by gel filtration chromatography. The gel filtration 
profiles and protein purity checked with NuPAGE are shown in Figure II -11 and Figure II 
-12 for Lsm2-3 and Lsm5-6-7 respectively. 
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Figure II -11. Purification of Lsm2-3. a) Elution profile of gel filtration chromatography 
from S200 26/60. b) Peak fraction at 218.9 ml was checked by NuPAGE. 
 
 
Figure II -12. Purification of Lsm5-6-7. a) Elution profile of gel filtration chromatography 
from S200 26/60. b) Peak fraction at 222.4 ml was checked by NuPAGE. 
 
3.2 Crystallization and data collection 





Figure II -13. Crystals of Pat1 C-regions alone and in complex with Lsm2-3. a) Semet-
Pat1-465c crystals. b) Semet-Pat1-473c crystals. c) Native Lsm2-3-Pat1-465c crystals.  
  Data collection statistics for these crystals are listed in Table 4. 
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Table 5. Se absorption edge collection for semet Pat1-465c and semet Pat1-473c 
Data collection  Pat1-465c Pat1-473c 
Derivative SeMet SeMet 
Wavelength (Å) 0.9795 0.9792 
Resolution (Å) 2.86(2.95-2.86) 2.82(2.91-2.82) 
Space group P212121 P21 
Cell parameters 
  a/b/c (Å) 53.9/91.3/131.2 36.9/176.6/174.4 
α/β/γ (°) 90/90/90 90/90.08/90 
Unique reflections 
(N) 19716 68572 
I/σ 4.4 (2.0) 5.6(2.4)       
Completeness (%) 99.9 (99.9) 100 (100) 
Rmerge (%)a 7.1 (37.1) 8.3 (30.8) 
 
Values in the highest resolution shell are shown in parentheses. 
a Rmerge = Σ|Ij-<I>|/ΣIj, where Ij is the intensity of an individual reflection, and <I> is the 
average intensity of that reflection. 
3.3 Identification of interaction networks among Pat1-465c and seven Lsm proteins 
from Lsm1 to Lsm7 
It is known that Pat1, possibly through the C-region of Pat1, can interact with Lsm1-7 
complex (Pilkington and Parker 2008); however it is not known which subunits of this 
complex interact with Pat1. To address this question, we used Native-PAGE to test the 
different combinations of Pat1-465c with all Lsm proteins (Figure II -14). Figure II -14 
shows that Pat1-465c has no interactions with Lsm4 (see lane 3 and 4) and Lsm5-6-7 (see 
lane 7 and 8). In contrast, a thick band appeared after mixing Pat1-465c with Lsm2-3 (see 
lane 5 and lane 6), which indicates that Pat1-465c binds to Lsm2-3 strongly. In accordance 
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with this observation, the amount of Lsm2-3 in lane 6 decreased when compared to the 
amount of Lsm2-3 in lane 5, which further confirms the interaction between Pat1-465c and 
Lsm2-3. However, it is not clear if Pat1-465c interacts with Lsm1 as the positions of the two 
proteins on the gel were very close (see lane 1 and lane 2). But it seems that the band density 
in lane 2 corresponding to the position of Lsm1 turned a little denser compared to the band 
density of Lsm1 in lane 1. Thereby it is possible that Pat1-465c also interacts with Lsm1 
although the interaction strength may not be as strong as the interaction between Pat1-465c 
and Lsm2-3. Lsm1, Lsm4, Lsm2-3 and Lsm5-6-7 were mixed at equal molar ratio and 
incubated at room temperature for 30 minutes and then loaded in lane 9. Of note, two major 
bands emerged, the lower band is likely from the abundant Lsm2-3 3 (compared to lane 5 
and lane 6 for the position of Lsm2-3) and the upper band seems to correspond to the 
position of Lsm4 (compared to lane 3 and lane 4 for the position of Lsm4). However a shift 
has occurred for Lsm 1 and Lsm5-6-7 in lane 9 when compared with lane 1/lane 2 for Lsm1 
and lane 7/lane 8 for Lsm5-6-7, based on the shift, it is possible that the upper band in lane 9 
may not be Lsm4 alone but be the Lsm1-7 complex. When Pat1-465c was added into the 
mixture of lane 9, the upper band and the lower band in lane 9 completely shifted up to form 
a sharp band just below the Pat1-465c band (lane 10). This indicates that the upper band in 
lane 9 is not the Lsm4 alone but may contain the complex of Lsm1-7 as Lsm4 alone cannot 
bind to Pat1-465c (see lane 3 and 4). Also, the lower band in lane 9 should correspond to 
Lsm2-3 as Lsm2-3 can interact with Pat1-465c strongly (see lane 5 and lane 6). Therefore, 
the sharp band in lane 10 may contain two components, the Lsm1-7-Pat1-465c eight-protein 
complex and Lsm2-3-Pat1-465c three-protein complex.  
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Figure II -14. Interaction networks between Pat1-465c and different Lsm proteins 
evaluated by Native-PAGE. Samples in each lane are shown at the left side of the gel. 
  Taken together, these results indicated that Pat1-465c interacts with Lsm1-7 efficiently and 
this interaction is mainly through the subunits of Lsm2 and Lsm3.  
  To test the model of Lsm1-7 in Figure II -6, different combinations of Lsm proteins were 





Figure II -15. Interaction networks of Lsm proteins by Native-PAGE. Proteins in each 
lane were labeled at the top left of each gel. 
 
  In Figure II -15a, two new bands appeared after mixing Lsm1 with Lsm2-3 as labeled with 
red arrows although the density of the two bands was weak. This indicates that Lsm1 can 
interact with Lsm2-3 but with low affinity. Lsm1 showed no interactions with Lsm4 and 
Lsm5-6-7 as indicated in Figure II -15b and Figure II -15c. Also Lsm2-3 failed to interact 
with Lsm4 (shown in Figure II -15d). In sharp contrast, a strong band appeared as labeled 
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with the red arrow in Figure II -15e, which indicates that Lsm2-3 interacts with Lsm5-6-7 
with high affinity. However, it is not clear if Lsm4 can interact with Lsm5-6-7 as the two 
proteins stack closely on the gel, making the results hard to interpret (shown in Figure II -
15f).  
  Taken together, our data are in agreement with the model provided by Naidoo et al. (2008). 
It seems that this heptameric Lsm1-7 ring complex is mainly contributed by the interaction 
between Lsm2-3 and Lsm5-6-7. The weak interaction between Lsm1 and Lsm2-3 and the 
lack of interaction between Lsm1 and Lsm4 indicate that incorporation of Lsm1 and sclms4 
into the heptameric ring structure is dependent on Lsm2-3 and Lsm5-6-7. 
3.4 Reconstitution of Lsm2-3-Pat1-465c, Lsm1-7 and Lsm1-7-Pat1-465c 
Reconstitution of trimeric complex containing Lsm2-3 and Pat1-465c is shown in Figure II -
16. A peak shift on the gel filtration was observed after the formation of the trimeric complex 
(eluted at 193.4 ml) compared to the peak position of Pat1-465c (228.6 ml from Figure II -7) 
and Lsm2-3 (218.9 ml from Figure II -11).  
  Recently, reconstitution of human Lsm1-7 have been reported by Zaric and coworkers 
(2005). Through analytical ultracentrifugation and electron microscopy, they found that 
human Lsm2-3 and Lsm5-6-7 are a ring-shaped and oligomeric structure in which Lsm2-3 is 
an octameric molecule [Lsm2-3]4 and Lsm5-6-7 a hexameric one [Lsm5-6-7]2. In order to 
disrupt the ring structure of the subcomplexes (Lsm2-3 and Lsm5-6-7) and reconstitute the 
human Lsm1-7 heptameric complex, they took a strategy with several steps as described 
below. Individual protein (Lsm1 and Lsm4) or subcomplexes (Lsm2-3 and Lsm5-6-7) were 
first incubated in 4M urea and 1M NaCl in a “semi-denaturaing” state for 2 h at 37 °C and 
then mixed in equimolar amounts for 2-5 h, and the sample was dialyzed overnight against 
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buffer with decreasingly salt concentration. Finally, the reconstituted human Lsm1-7 
complex was purified by gel filtration and anion exchange chromatography. Unlike their 
time-consuming strategy, we took a fast but efficient approach to reconstitute Lsm1-7 and 
Lsm1-7-Pat1-465c. Instead of using the semi-denaturing of samples in 4M urea, a thorough 
denaturing of samples were conducted in 8M urea, followed by direct on-column refolding 
and reconstitution of the Lsm1-7 and Lsm1-7-Pat1-465c simultaneously. This strategy has 
been successfully used for the sample preparation and structural solution of apo-spuD and 
apo-spuE in the first part of my thesis. 
  Reconstitution of Lsm1-7 seven-protein complex is shown in Figure II -17. A noticeable 
peak shift occurred when compared the peak position (208.9 ml in Figure II -17) with the 
peak positions of Lsm1 (229 ml from Figure II -9), Lsm4 (244.5 ml from Figure II -10), 
Lsm2-3 (218.9 ml from Figure II -11), and Lsm5-6-7 (224.4 ml from Figure II -12).  
Reconstitution of Lsm1-7-Pat1-465c eight-protein complex is shown in Figure II -18. The 
peak position of Lsm1-7 shifted forward from 208.9 ml (Figure II -17) to 201 ml (Figure II 
-18) after incorporation of Pat1-465c. The NuPAGE gel clearly showed eight bands 
corresponding to the eight proteins (Figure II -18).  
  Together, these shifts observed during the process of reconstitution also confirm our Native-




Figure II -16. Reconstitution of Lsm2-3-Pat1-465c. a) Elution profile of gel filtration 
chromatography from S200 26/60. b) Peak fraction at 193.4 ml was checked by NuPAGE. 
 
Figure II -17. Reconstitution of Lsm1-7 complex. a) Elution profile of gel filtration 
chromatography from S200 26/60. b) Peak fraction at 208.9 ml was checked by NuPAGE.  
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Figure II -18. Reconstitution of Lsm1-7-Pat1-465c complex. a) Elution profile of gel 
filtration chromatography from S200 26/60. b) Peak fraction at 201 ml was checked by 
NuPAGE. 
 
3.5 mRNA binding properties  
Although it is known that Lsm1-7-Pat1 can bind with oligo (U) (Chowdhury et al. 2007), it is 
not known how each of the eight proteins participates in this binding. To this end, SPR was 
employed to test the binding of Lsm proteins to 5’ biotin-labelled 15-mer poly (U). As shown 
in Figure II -19, Lsm1-7 seven-protein complex binds to poly (U) with a dissociation 
constant (Kd) of 41.3 nM, while the binding affinity of Lsm1-7+Pat1-465c complex towards 
poly (U) (Figure II -20) decreased to around half that of the binding affinity between Lsm1-









Figure II -20. Binding of Lsm1-7-Pat1-465c complex and 5’ biotin-labelled poly (U). 
 








  Lsm2-3 showed high binding affinity to poly (U) with a Kd of 21.2 nM (Figure II -21). 
Similarly, the trimeric complex of Lsm2-3-Pat1-465c displayed reduced binding affinity 
towards poly (U) (Kd = 51.5 nM) (Figure II -22).  
 
 





Figure II -22. Binding of Lsm2-3-Pat1-465c complex and 5’ biotin-labelled poly (U). 
 
  It seems clear that Pat1-465c decreases the binding between Lsm1-7 or Lsm2-3 and poly 
(U) to approximately half level. Sensorgram of Pat1-465c binding revealed a fast-association 
and fast-dissociation pattern, which may indicate that the binding mainly occurs through 
electrostatic interactions between the positively charged surface residues of Pat1-465c and 
negatively charged phosphate groups in poly (U) (Figure II -23). In contrast, Lsm1, Lsm4 




Figure II -23. Binding of Lsm1, 4, 5-6-7 and Pat1-465c towards 5’ biotin-labelled poly 
(U). 
 
   Together, it seems that the RNA binding property of Lsm1-7 can be largely attributed to 
Lsm2 and Lsm3, while Pat1-465c has a negative regulatory effect on RNA binding. Two 
conserved and heptameric lsm protein complexes have been identified: theLsm1-7 complex 
which is located in the cytoplasm and involved in mRNA decay, and the Lsm2-8 complex 
localized within the nucleus and involved in pre-mRNA splicing. Lsm2-8 is not involved in 
cytoplasmic mRNA decay, but plays a role in the decapping and degradation of pre-mRNAs 
and nucleus-restricted mRNAs (Kufel et al. 2004). As the two heptameric Lsm protein 
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complexes have close associations with RNAs, their common components, namely, Lsm2, 3, 
4, 5, 6 and 7, may be the core components for RNA interactions, while the unique 
components in each of the two complexes, Lsm1 in the Lsm1-7 complex and Lsm8 in the 
Lsm2-8 complex, may determine the functional sites of the complexes, whether in the 
cytoplasm or in the nucleus. From our SPR data, Lsm2 and Lsm3 might be the major factors 
for RNA binding in both Lsm1-7 and Lsm2-8 complexes. Currently, more efforts have been 
employed to determine the role of Lsm1 in the cytoplasmic mRNA decay (Tharun et al. 
2005; Chowdhury and Tharun 2008; 2009), while few report has addressed the roles of these 
common components in mRNA decay. All together, the preliminary results in this study 
suggest that Lsm2 and Lsm3 might play a more important but yet unidentified role in the 
process of mRNA decay apart from being merely scaffolding ring-structure proteins. In 
support of this hypothesis, Pat1-465c interacts with Lsm1-7 complex mainly through the 
binding of Lsm2 and Lsm3. 
3.7 Difficulties in structure determination of Pat1-465c and Pat1-473c 
The C-region of Pat1 bears low sequence identity to other proteins, thereby hampering efforts 
to solve the structure using the molecular replacement method. 
Crystals of the C-region of Pat1 were grown with seleno-methionine substitution.  Seleno-
methionine-substituted Pat1-422c was purified, crystallized and data was collected. However, 
the highest resolution achieved was 3.6 Å and the selenium heavy atom sites could not be 
identified clearly (Data not shown). The diffraction quality of this crystal did not improve 
although extensive optimizations including additive screening, seeding, dehydration and 
annealing were performed. Based on secondary structure predictions, a shorter construct 
(Pat1-465c) was made. Seleno-methionine-substituted Pat1-465c crystals appeared after a 
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few hours. Although, a resolution of 2.5 Å was reached, the Pat1-465c crystals showed 
twinning and selenium heavy atom sites failed to be traced out. A further shorter construct 
was made (Pat1-473c), deleting eight residues at the N-terminal of Pat1-465c, however this 
construct similarly yielded twinning problems. Primary sequence information showed that 
Pat1-473c contains a high percentage of lysine residues (27 Lys out of 323 residues or 8%). 
We suspect that the positively charged Lys residues located on the surface of Pat1-473 might 
be the determining factor for twinning formation through salt bridge interaction with other 
negatively charged surface amino acids. To solve the structure of the C-terminal region of 
Pat1, the future work is to (1) systematically mutate the Lys residues in this region of Pat1, 
(2) make more constructs within this region, and (3) study its homologues from other species 
such as Homo sapiens or Schizosaccharomyces pombe. The future work also goes to obtain 
diffraction quality crystal of Lsm2-3-Pat1-465c.Our ultimate goal is to solve the structure of 
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